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Squash inhibitors are the smallest natural serine protease inhibitors. Their compact, 
rigid nature has enabled detailed examination of their 3D structure by NMR and X-ray 
crystallography. Being of a convenient size to synthesise chemically, the effects on 
activity of selective substitutions and deletions within the sequence have also been 
investigated. Thus, this family of inhibitors is considered useful as a model system for 
the study of protein-protein interactions. 
ClfClfrbila maxima trypsin inhibitor I (CMTI I) may be thought of as representative of 
the squash inhibitors, for which there is detailed structural and functional information 
available. It is a 29 amino acid protein, with the tri-disulphide bridging pattern common 
to all squash inhibitors. 
There are only a few examples of squash inhibitors being produced by recombinant 
DNA technology. As this technique offers a relatively cheap way of producing large 
amounts of these proteins, further investigation is required. Problems have been 
experienced with the expression of disulphide-rich proteins in E. coli, as the cytosol of 
this microorganism is not conducive to their folding. Furthermore extraction of these 
proteins from the peri plasmic space is often required, resulting in a reduction in yield. 
To overcome these shortcomings, the methylotrophic yeast Pichia pastoris was 
investigated as an alternative means of expression, although at the inception of this 
work, no disulphide-rich proteins of this size had been expressed in P. pastoris. It was a 
challenge to investigate the feasibility of producing squash inhibitors in this expression 
host and to compare the activity of the recombinant inhibitor to that of native CMTI I. 
An oligonucleotide coding for the sense strand of the CMTI I sequence was chemically 
synthesised. PCR amplification was used to introduce a recognition site for the enzyme 
enterokinase at the 5' end of the CMTI gene sequence in addition to restriction sites for 
cloning into plasmid PIC9. Determination of the orientation and sequence of the gene 
were carried out by first cloning the construct into E. coli. The recombinant plasmid 
was then transformed into spheroplasts ofP. pastoris using electroporation. 
II 
Iransformants exhibiting a methanol-utilisation-slow phenotype were for 
inclusion the at the genomic AOX1 locus by peR. 
containing the modified CMTll were the recombinant 
product, direct assay induced culture supernatants for anti-tryptic activity. 
procedure was then developed to isolate the inhibitor. isolate was subsequently 
identified using amino acid analysis and protein sequencing. The N-terminus of this 
protein was trimmed by with enterokinase and the product identified as a 
recombinant form of eMIl I, equivalent to the native protein. 
Inhibition constants were determined for both recombinant inhibitors as well as for 
native eMIl 1. The inhibition constants are 3.3 x 1 a·7M, 2.11 x 1O-7M and 
217 x Ja·7M respectively for the fusion protein, recombinant eMIl I and native eMIl 
I. results show that all inhibitors have Ki of similar magnitude. As the 
structure and activity squash inhibitors are intimately linked, it can be readily 
concluded that pas/oris is capable of synthesising folding active eMIl 1. It is 
further shown that of of eMIl I by 
had little on the inhibition constant 
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are enzymes which peptide bonds. were discovered the turn of 
studies properties of gastric juices. For instance, a component of 
acid was shown to convert enzyme prosecretin to secretin (Bayliss and Starling, 
1902). the number of discovered grew, so need for their ", ... ..,.:...uv,..."-'.. 
into various mechanistic sets. Methods used in the 1 
studies of kinetics for of substrate and susceptibility 
inhibitors. chemical analysis common features were 
such as of an for activity subsequently 
the acid prot eases. At the forefront techniques used to proteases 
and' was crystallography. enabled elucidation folding properties as well 
as situation and of Examples include X-ray structure papam 
(Drenth, J. J. A (Lipscomb, W. , ] 969). 
Despite two sharing the same mechanism of action, tertiary structures 
quite different. s is exemplified chymotrypsin and subtilisin which are both 
prot eases, yet conformation. essential residues 
catalysis different positions their primary sequence, substrates bind to both 
enzymes In a manner. Thus which exhibit folding and geometry 
of the active site, may have low sequence homology, were v,,,,.,.,,,u into sub-groups. 
Chymotrypsin. and elastase are a of serine which are closely 
related in terms structure and yet 40-50% amino homology. This 
led to the a common primordial gene for these enzymes which mutated in 
structurally important sequences, but not in the catalytic residues. The evolutionary 
signifIcance of is demonstrated by that trypsin has found in a wide 
variety of organisms cattle, and (Reich, 
and Shaw, 1 
1 
The first characterised were those found in abundance in various and bodily 
fluids. They considered to a nature, their purpose to proteins 
for nutritional reasons. With more refined detection, 
less abundant which are more difficult to isolate were molecular 
biology techniques were used for probing DNA for "v,",,,,,!". ""<"Y"I1,",'__" with homology 
to known These proteases to be more versatile structure and 
function. exhibit a limited proteins, often the adaptation of a protein to 
its . As enzymes, their activity is to be specific 
and in order to avoid all out in their vacinity. It is 
here play an important In 
2 
1.2 The Serine Proteases 
The serine proteases are the largest family of proteases. Serine in the active cleft is pivotal to 
their mechanism of action, hence their name. The shape of this cleft determines the substrate 
for the enzyme as only certain residues will "fit". For instance, trypsin has a long, narrow 
cleft which accommodates basic amino acid side chains such as those of arginine and lysine; 
while in chymotrypsin this is shallow and wider, hence more bulky residues such as valine 
will bind. 
Common to all serine proteases is a means of "charge transfer" which enables a bond to be 
established between Ser195 (trypsin) and the carbonyl carbon of the peptide bond to be 
cleaved on the substrate (see figure 1). Serine is usually an unreactive amino acid but, its 
position in the enzyme active centre next to a positively charged histidine ring (His95 in 
trypsin), allows serine to loose a proton to His95 and so become negatively charged. 
Protonation ofHis95 is in turn favoured by the presence of aspartic acid (Asp 1 02 in trypsin) 
which has a negatively charged side chain. As this transfer of negative charge comes into 
playa simultaneous cleavage of the substrate peptide bond occurs. The N-terminal portion of 
the now cleaved substrate moves away leaving the C-terminal portion still bound to the 
enzyme. At this point water binds to the enzyme in place of the departed polypeptide, 
transferring a proton to His95. In effect the charge transfer mechanism is reversed with 
Ser195 once again becoming neutral, and release of the C-terminal portion of the cleaved 
substrate. Thus is the active cleft of a serine protease regenerated for proteolysis of another 
substrate. 
3 
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1.3 Serine rotease Inhibitors 
Serine protease inhibitors have been grouped into at least 16 families on 
between their sequences, tertiary structures and mechanism of binding. Many of these 
inhibitors and hence their structures have been elucidated from diffraction 
patterns Most serine inhibitors react in a substrate-like mechanism, as 
competitive That is, they are not bound to the but rather 
compete with a substrate for the most commonly adopted to describe 
where an lies in the primary of an inhibitor, reactive site 
bond, is that of Schechter and Berger (1 The residue at which bond cleavage 
occurs IS the Pl residue, the bonded to its C-terminus P 1 '. Residues to 
and terminals of these two amino acids are termed as follows: 
PI - PI' - P2' ­
arrow indicates the site 
inhibitors share a common general structure whereby the active site is "H"'U''',U 
on a loop from core inhibitor, and is able to into the cleft of the 
Apart from this unrelated in structure, This binding loop is 
"''''-''V,,"'_'' to the solvent even residues tend to in nature, It is 
in place in the enzyme cleft by a scaffold provided by inhibitor core, as as 
between the core which flank (Bode and 
binding loop usually quite rigidly in the cleft. In the case of trypsin 
hydrogen bonds are between the binding loop and residues Gly193N 
of trypsin, it is the cooperative and nature of the' 
the inhibitor core loop which most to this 
crystallography Nrv1R have proven useful in unraveling 
structures of both free and enzyme bound inhibitors, crystallography has 
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Both X-ray crystallography and NMR have proven extremely useful in unraveling the 
structures of both free and enzyme bound inhibitors. X-ray crystallography has provided 
detailed information on the tertiary structures of free bovine pancreatic trypsin inhibitor 
(BPTI) (Deisenhofer and Steigermann, 1975); BPTI bound to Pbovine trypsin (Huber et al, 
1974; Marquart et ai, 1983); anhydrotrypsin (Huber et ai, 1975; Marquart et ai, 1983) and 
bovine trypsinogen (Bode et a11978; Marquart et aI1983). NMR was used to illucidate the 
structure of the potato CI-2 inhibitor (Clore, G. M., et ai, 1987). Grasberger et ai, (1994) 
used NMR spectroscopy to show the Ascaris trypsin inhibitor is active at low pH because 
only then does it fold into the canonical shape of a serine protease inhibitor. 
The specificity of inhibitors of the chymotrypsin-like proteases is determined by the side 
chain of the PI residue, as this interaction is the most important in terms of energy required 
(Laskowski et ai, 1987). Changing this residue can often alter specificity to that of another 
enzyme. By synthesising variants of Cucurbita maxima trypsin inhibitor III (CMTI III) with 
substitutions at the PI position, McWerter et ai, (1989) produced inhibitors against human 
leukocyte elastase and cathepsin G. Natural CMTI III inhibits trypsin as it contains arginine 
at the PI position and this experiment demonstrates the simplicity with which inhibitor 
specificity can be changed. A few natural inhibitors have been shown to inhibit more that 
one protease: an interesting and unusual example being that of ecotin. This 142 amino acid 
protein is found in the periplasm of E. coli and exhibits activity against trypsin, 
chymotrypsin, elastase, factor Xa and kallikrein. Methionine was found to be the active site 
residue of this inhibitor in all cases. The side chain of methionine was found to "mimic" the 
"preferred" side chain for fitting in to the enzyme cleft. For instance, when bound to trypsin, 
it was found in an extended conformation similar to lysine (McGrath, M. E., et aI1995). 
The reaction mechanism for serine protease inhibitors may be expressed by following the 
general model: 
Figure 2. Kon Koff* 





where, E is the enzyme; I the free inhibitor; EI the enzyme-inhibitor complex and I* the 
cleaved inhibitor (Finkenstadt, W. R., et al1974; Quast, V., et al 1978). 
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rate of reaction for Kon is much faster than that for Ko/f*, implying the EI complex forms 
rapidly, with a slow dissociation to yield the modified inhibitor. Despite this, the complexes 
formed between unmodified and modified inhibitor and the enzyme were found to be equally 
stable in thermodynamic terms (Laskowski, M. Jr., Sealock, R. W., 1971). At neutral pH, the 
value for the hydrolysis of the peptide bond by the cognate enzyme, as expressed by the ratio 
Kcal / Km, is high for an inhibitor, compared to that of a substrate (Laskowski and Kato, 
1980). Small changes in the conformation of the binding loop on complex formation, as 
investigated by X-ray crystallography and NMR (see above), have provided some in-sight in 
to the differences between substrate and inhibitor binding. 
Making use of the structural, thermodynamic and kinetic data available, recent work has 
utilised computer modeling to predict which residues are essential for activity. These ideas are 
subseC]uently validated by measuring activity following the appropriate amino acid 
substitutions and/or deletions. This may be done by chemically synthesising the varient or by 
cloning the gene with appropriate changes to the base sequence. Some groups have taken 
modeling experiments a step further by designing chimeric proteins able to inhibit more than 
one protease. These "multi-headed" inhibitors (having more than one enzyme binding site) do 
exist in nature. For instance, Rhodes el al (1960) showed that inhibitors known as 
ovomucoids from a number of avian species are single, double or triple headed. Le-Nguyent 
el aI, (1989), chemically synthesised a 32 residue protein with the active site of Ecballium 
elalerillm trypsin inhibitor, a squash inhibitor, and the C-terminal tetrapeptide of potato 
caboxypeptidase inhibitor. This synthetic, "double headed" inhibitor showed some loss of 
activity to trypsin in addition to an almost identical inhibition of carboxypeptidase A 
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1.4 The squash family of inhibitors 
Inhibitors found in the seeds of the Cucurbitaceae are commonly known as the squash family 
of inhibitors . Polanowski et al (1980), were one of the first groups to isolate two trypsin 
inhibitors, with molecular mass of 3300D each, from squash seeds. They were later named 
Clfc1frbita maxima trypsin inhibitors I and III (CMIl I, CMTI III), according to the elution 
times of peaks with anti-tryptic activity after chromatography. CMTI I and CMTI III differ 
only at residue 9: in CMTI I this is Glu and in CMIl III it is Lys. Examples of this group of 
plants include summer squash, zucchini, and watermelon from which inhibitors have all been 
isolated (Otlewski, land Wilusz, T, 1985; Leluk, 1., et a11983; Polanswski, A, et aI1987.). 
Squash inhibitors constitute the smallest natural serine protease inhibitors, ranging in length 
from 27 to 32 amino acids. Due to their stable, rigid conformation, in addition to being small 
enough to be chemically synthesised, there has been much interest in this group as a model 
system for the study of protein-protein interaction. As they are relatively insensitive to pH and 
temperature, harsh conditions can be employed in their extraction. For example, Matsuo et al 
(1992) isolated two squash inhibitors from bottle gourd , by first extracting with 10mM 
(N"1L)2CO~ ; followed by acetone precipitation and four stages of reversed phase HPLC. 
The reactive site always lies between residues five and six: the side chain of the PI residue 
determining specificity (Otlewski, 1., 1993). Because this is arginine, or in some cases lysine, 
squash inhibitors with few exceptions, display anti-tryptic activity. It can be argued that this 
resulted from investigators isolating new squash inhibitors by screening solely for antitryptic 
activity, for instance, using trypsin immobilised on an affinity column. Consequently, the 
enzyme/s they inhibit ill vivo may well remain unknown, although several groups claim to be 
using a variety of proteases in their isolation procedure. Indeed, exceptions to the anti-tryptic 
activity of squash inhibitors have come to light with the discovery of several elastase 
inhibitors from the seeds of bitter gourd , in which the PI residue is leucine (Hara, S., et ai, 
1989; Hamato, N, et ai, 1995). 
The inhibitor binding loop consists of residues 2 to 8 in the primary sequence, of which Va12, 
Pr04 and I1e6 are in contact with the enzyme. The positions of six half-cystines are conserved, 
8 
conserved, which are responsible for the structure-function relationship of these inhibitors. 
An aromatic residue is found at either position 7 or 27, but not at both, and a His-Glu-Glu 
tripeptide is situated at the N-terminus of two squash inhibitors. From the latter it has been 
postulated that this family of inhibitors arose as a product of limited proteolysis of one gene 
product, instead of as the products of individual gene expression (Otlewski, 1.,1993). The 
majority of conserved residues are those involved in direct contact with the enzyme, apart 
from the six half-cystines. The sequences of ten squash inhibitors are tabulated as follows: 


























Wilutz et al (1983) 
Wieczorek el.1 1985) 
Wieczorek el al 1985) 
Wieczorek el 31 ( 1985) 
Favel et al (1989) 
Hara et al (1989) 
Hara et al (1989) 
Hakateyama et al 1991 
Matsuo el al (1992) 
Huang et al (1990) 
Modified from Otelwski, 1. (1993). (* =pyroglutamic acid) 

Highlighted letters represent concerved cysteins and the reactive site PI-PI' residues 

Squash inhibitors exhibit little secondary structure: there are two reverse turns between 
residues 17 to 20 and 23 to 26; one turn of an 310 helix from Asp 13 to Cys 16 and a short 
antiparallel ~-sheet from Cys20 to Gly29 (Otlewski, 1., 1993). Thus tertiary structure is 
highly dependent on disulphide bridge formation. The topology of disulphide bridges in 
squash inhibitors is as follows : 
9 
I I 
3 10 16 20 22 28 
Various methods were used to establish this pattern, as previous structural predictions, based 
on comparing the sequences of squash inhibitors to that of wheat germ agglutinin, proved 
incorrect. For example, 1 H 2D NMR was performed on a synthetic form ofEcballium 
elalerilll11 (squirting cucumber) trypsin inhibitor II (Heitz. A., et al, 1989) in order to 
elucidate S-S conectivities. Hara, S ., el al (1989) elucidated the disulphide bridging pattern of 
natural Momordica charalllia (bitter gourd) trypsin inhibitor II (MCT! II) by partially 
digesting the intact molecule with thermolysin, after attempts at cyanogen bromide digestion 
failed . Fragments generated were separated by HPLC and those containing cysteins 
determined by amino acid analysis. These peptides were subsequently reduced, the cysteins S­
pyridylethylated and a further separation by HPLC performed. Sequencing of these final 
peptides enabled them to establish the disulphide bridging pattern. In all cases studied so far, 
disulphide topology has been found to conform to the above pattern. 
Structural similarities have been noticed between small proteins relying on a tri-disulphide 
pattern for tertiary structure. They have been named the "knottins" and as such, squash 
inhibitors may be included in this class along side a number of unrelated proteins, such as the 
CD-toxin from the funnel web spider. (Liang Lin, S. and Nussinov, R., 1995).The structure of 
these proteins is roughly that of a letter T, with three loops held in place by two of the 
disulphide bridges. The third bridge is used to link the active site to the second loop : for 
squash inhibitors this being the active site loop at the N-terminus. Many other proteins show 
similarities to the knott ins but tend to have more extensive secondary structures. What is 
important about the T-knot scaffold is that secondary structures are distinctly lacking in this 
group such that the disposition, number and pattern of disulphides must be subject to certain 
architectural rules to ensure full protein activity. 
Investigations into structure-function relationships have centered around chemical synthesis 
of squash inhibitors and their analogues, with substitutions and deletions in the amino acid 
sequence. Kupryszewskki el al (1986) chemically synthesised CMT! III by the Merryfield 
10 
solid comparing the immunigenicity of rabbit antibody against 
natural of their they were able to confirm the inhibitor 
as the 29 amino 3 disulphide-bridged structure proposed by et in] 983. This 
was further by UV and CD Initially some 
disagreement over the sequence and disulphide amino acid, 2 
disulphide-bridged structure being published for CMTI III two (Nowak et ai, 
1). 
Rolka et at (1 1) chemically CMTI III substituting for ArgS in the PI 
position in to attain anti-chymotryptic activity. To potency of this 
they introduced part of the the avian ovomucoid third in positions 
P4 . " which is known to be a chymotrypsin inhibitor. analogue, with 
simply a substitution ofPhe at PI, was shown to be a poor inhibitor of chymotrypsin while 
construct was strongly anti-chymotryptic, with an inhibition constant (Ki) of 
6 x 10- 11 M. Prior to this they replacement the Pl with Val produced an 
inhibitor (Rolka, K., 1 concluded that PI therefore 
with amino acids in binding loop providing contacts with the 
pocket and hence important for enzyme-inhibitor complex formation. 
outside the have provided further evidence in support of above. 
truncated at 2 residues, one residue at the C-terminus, 
was fully active, as were substitutions in non-contact 
regions. (Rozycki, 1., et aI1994). year, this in a more dramatic 
an analogue of CMTI III with the removal of four and simultaneous substitution ammo 
(Rozycki, 1, el al 1 This inhibitor showed a Ki of the same order as CMTI III and 
IS shortest inhibitor to date, residues in length. 
potential of squash inhibitors and ."'1\..1"'-,• ...,,, as therapeutic compounds received 
some attention in recent They have been blood 
coagulation system, in usually been a type of approach. et al 
(1994) isolated 8 squash inhibitors from various of the Cucurbitaceae and 
investigated their toward enzymes of the intrinsic and extrinsic blood coagulation 
cascades Only II a significant prolongation of the extrinsic blood coagulation 
11 
1 
time due to its inhibition XIIa, with a Ki of 5.6 x 1 M, Wynn and 
Laskowski (1990), inhibition Factor XIla by 
Cucurbita Maxima Trypsin Inhibitor I 
CMTI 1has been mentioned a times in the preceding because it is the 
characterised of the squash inhibitors. 1989, collaboration Max-Planck 
institute in Germany and the ofWroclaw, Poland, solution structure 
I by l\1\1R (IHolak, Wilusz, 1989). these 
published a comparison conformation of the binding loop solution (by 
In a trypsin bound state (by crystallography). Their was stringent 
to afford accurate calculations which showed there to be little difference 
the structure of the bound and unbound binding loop, Huber, 
Wilutz, 1989), a approach the 3D structure was by 
Nl\1R in ]991. (Nilges, M., el aI, 1991) 
The amino acid sequence of I is in table 1. It is a 29 amino polypeptide, the 
bond lying between and CMTI I may be considered a strong 
trypsin with inhibition constants in the order of 10-8 -1 M. A 
exists between Ki reported from groups, which explained by non 
uniformity assays used as well as in measuring high constants 
(Otlewski, L 1993), 
Otlewski and (1994) investigated and resynthesis of bond in 
the I with ~ bovine reaction was performed in four 
buffers from 3.2 to 8.3 At various time intervals, an aliquot was and 
subjected to ion-exchange HPLC. The ratio of two peaks to 
cleaved and ofCMTI I were at each time. A value of21.6 was 
obtained for ratio of Kon / K *on, showing that association constant for intact 
inhibitor is than for the cleaved inhibitor. index, CMII 
I-~ bovine is high, but this OelJen,Oelrlt on an extremely low for 
the inhibitor a value for In this CMTI I, like other squash inhibitors, 
differs from a substrate. Added to this, thermodynamic data provided further evidence that 
slow hydrolysis of the active site bond was due to conformation of the inhibitor binding loop 
"locking the protease in a highly populated noncatalytic state" (Otlewski and Zbyryt 1994). 
They concluded that CMTI I conforms nicely to the standard mechanism. 
Figure 3. 
Computer simulated model of CMTI I in the active site cleft of trypsin (Arg5-Ile6 active site 
bond in yellow). Curtesy of Dr. D. Maeder, Dept. of Biochemistry, University of Cape Town. 
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2.0 The Production of Recombinant Proteins in 
Yeast 
2.1 Introduction 
The manipulation of microorganisms for the production of heterologous proteins has had a 
significant impact on both science and industry. The bacterium Escherischia coli continues to 
playa centra} role in cloning, for which there are many commercial strains and expression 
plasmids available. However, there are several short-comings to bacterial expression. 
Although high yields can be obtained, the product may not be a satisfactory representation of 
the native protein. Proteins are often sequestered in the periplasmic space in insoluble 
inclusion bodies, necessitating their extraction and purification. As this usually involves 
denaturing and renaturing the protein, the final product may be incorrectly folded, thus 
impairing activity Microorganisms like L', coli cannot glycosylate proteins and the N-terrninal 
methionine is often retained. Cloning mammalian genes in E. coli can also be problematic if 
the foreign mRNA requires extensive methylation. In addition, bacteria do not splice introns 
correctly. 
The genetics and physiology of Saccharomyces cerevisiae, otherwise known as Bakers or 
Brewers yeast. have been extensively investigated. With this knowledge came the realisation 
that yeast could be used as an alternative to bacteria for the expression of recombinant 
proteins. Yeast are eukaryotes, and as such, their potential for producing eukaryotic proteins 
of superior quality to those produced by bacteria, has been of particular interest. Yeast can 
reproduce both sexually and asexually, depending on environmental conditions. Their genetic 
material is carried on 34 chromosomes. Vectors for S. cerevisiae are based on the naturally 
oeeuring, :2 mieron plasmid whieh is found in high copy number and segregates through 
meiosis in a stable manner. 
Yeast show transcriptional and translational features of higher organisms. For instance, yeast 
mRi'JA is 5' capped and is extended by poly(A) at the 3' end, while translation initiates from 
the first AUG. Cellular organelles similar to those found in higher eukaryotes are present, 
14 
such as mitochondria, rough endoplasmic reticulum and lysosomes. Proteins of homology to 
those in plants and animals have also been characterised including histones, peptide hormones 
and actin. 
Several factors make S. cerevisiae attractive as an expression host: It can be manipulated in a 
prokaryotic manner, for which protocols are well established and numerous. Many 
auxotrophic markers for selection of transform ants are available, in addition to commercial 
host strains. As S. cerel'isiae contains a eukaryotic secretory pathway, recombinant proteins 
may be modified in a manner similar to that of higher organisms. For instance, unlike bacteria, 
,)'. cerel'isiae is able to glycosylate proteins. Recombinant proteins can be secreted into the 
medium allowing for easier isolation. Finally, of commercial interest is the classification ofS. 
cerel'isiae as a "generally regarded as safe" (GRAS) organism. The FDA awarded its first 
license for a yeast-produced therapeutic compound, for the production of hepatitis B surface 
antigen (HBsAg), in 1987. HBsAg was produced as unglycosylated, but nevertheless, 
immunoreactive particles of the same molecular weight as those produced by E. coli 
(Valenzuela, P., 1982). 
Even so, problems have arisen from the application ofS. cerevisiae as an expression host. 
'Yields tend to be poor, usually only up to 5% of total cell protein (TCP) This can be due to 
plasmid instability although various types of yeast vectors, containing stabilising sequences, 
have been developed to overcome this. For instance, the inclusion of both autonomously 
replicating and centromeric sequences has resulted in vectors that behave like circular 
minichromosomes and are thus stable throughout meiosis. Difficulties in scaling up have been 
reported as well as susceptibility to toxicity resulting from the intracellular accumulation of 
some recombinant products (Struhl, K., 1983). Similar to E. coli, some proteins are not 
secreted but sequestered in the periplasmic space, from which they must be extracted and 
purified. This often becomes necessary for large proteins which do not easily pass through the 
cell wall of S. cerel'isiae, thus leading to a reduction in yield (Romanos, M. A., el aI1992). 
Finally, S. cerel'isiae has a tendency to hyperglycosylate proteins which can lead to an 
impairment in activity. Consequently, alternative yeast genuses have been studied as tools for 
recombinant protein expression. 
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2.2 Pichia pastoris as an Expression Host 
Pichia is a genus of yeast first isolated in 1922, France, from the exudate of the chestnut tree 
(The Yeast, 1970). Members of this genus are able to utilise methanol as their sole carbon 
source. Alcohol oxidase is the first enzyme in the methanol utilisation pathway, catalysing the 
oxidation of methanol to formaldehyde (Anthony, c., 1982). It is found in abundance in 
Pichia pas/oris and under optimal conditions represents up to 30% TCP. Alcohol oxidase is 
the product of two near-homologous genes: AOXI and AOX2. of which AOXI produces the 
vast majority. Transcription of the AOXI gene is directed by a tightly regulated, methanol­
induced promoter. The exploitation of this gene and its promoter have enabled the 
development of P,chia pas/oris as a powerful tool for the expression of recombinant proteins. 
Budding cells of P. pastoris, strain GS115, taken at 400x 
magnification 
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AJI Tn ...·""f-·fl in P. pasioris have been subject to the principle 
from product formation. This division is known to 
depletion of proteins and factors necessary for cell 
the over-expression of a foreign protein. The AOX} promoter is both 
and glucose, and induced by methanol. Thus, basic 
involves cloning the interest downstream from the AOX} promoter, obtaining 
satisfactory on glycerol, and then replacing the glycerol 
induction and hence protein expression. 
P. pas/oris has no vectors and as such, integrating vectors 
developed (Romanos, M., ] into the genome is advantageous in 
stability through to be passed on through generations 
without having to for genes carried on episomal 
vectors. Vectors for both protein production have been 
produced. Those medium contain the gene for a secretary 
signal upstream signal sequence may be 
employed, it is usually The most commonly used has been the ex 
mating (ex s. Other signal sequences include that 
from the acid phosphatase and invertase SUC2 gene (Romanos, M., 1995). 
Common features of vectors for include: 
• Bacterial sequences (usually pBR322) and an antIDIC)UC marker for cloning in E. coli. 
• HIS-I for selection of transform ants in 
• The AOX} promoter region. 
• A multiple cloning site downstream from the promoter. 
• AOX} genomic sequences for transcription 
• AOX} genomic sequences to afford integration oflinearised at locus. 
Plasmid PIC9 is a typical secretory vector for P. is shown 
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(Reproduced manual 3) 

It is usual to generate several of transformants, depending on the at which the 

plasmid is Iinearised and the of the host cell GS 115 has the host line most 

often containing a mutation in the histinadol dehydrogenase 4 (his4) 
selection of transformants. pPIC9 with Bgl II above) will 
One contains sequences and has no to play 
the procedure. The other, containing the construct, is directed 
to integrate at the AOXl locus because it has ends homologous to this gene. 
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In up to of 115 transformants, a transplacement event will take place such that the 
AOXl gene is by Bgl II-cut fragment. no structural AOXl 
these transformants slowly on methanol because on the less efficient 
AOX2 gene for alcohol production. named methanol 
utilisation slow mutants (Mut'). An number of Bgi II 115 transformants 
may have a positive (Mut -) phenotype, an integration event at 
either the AOXl or loci, with the gene remaining intact. In addition, a number of 
"transformants" will containing no vector and are to be clones in which 
the his-l gene has converted to the wild type HIS-I (Romanos, M., 1995). 
Cutting pPIC9 with Sal I will in a population of clones, the which 
exhibit a Mu( phenotype, ,",,",au,,,", the insert was directed to to transplace, 
at the HIS-I or AOXl loci. It proven that either is preferable for 
the production of one However, it is useful to both MutS and Mut + 
phenotypes to increase isolating a super-secretor. Some favour the 
faster growing Mut - clones, on of protein secretion being limited to 
located in the budding yeast (Romanos, M., 1995). et al 
(1987), in an attempt to explain the superior expression levels from their Mut' transformants, 
the longer generation on methanol allowed more folding 
recombinant HBsAg particles. 
A number of investigators multiplicity is an important factor in 
yields. Both Mut- and MutS clones have the remarkable ability to insert 
copies of the gene, as at the targeted genomic locus. exact 
means by which this happens is not yet known, but it has been suggested that 
self-ligate before repeated head-to-tail insertion into the genome et ai, 
group showed a relationship yield and the number of tandem a 
by isolating several MutS phenotype, pvr.rpc 
for tetanus toxin fragment C. A maXImum 14 
yield of 10.5% TCP culture and 27% by fermentation. Shortly 
used hybridisation DNA to isolate transformants 
LUWlIU."i multiple copIes of the mouse factor (mEGF) gene. A 
19 
containing 19 integrated copies of the mEGF gene was found, which under fermentation 
conditions secreted 450~g/ml of mEGF (Clare,2 1. 1., et ai, 1991). 
Listed below is a selection of proteins expressed in P. pastoris, together with points of 
interest from each publication: 





Cregg. J. M., et 
surface antigen 
1987 High % of product assembled into 
22nm particles, similar to those ai, (1987) 
Bioffech 5,found in humans. Superior secretion 
479-485. 
Human tumor 
in MutS clones. 
Antitumor protein originally Sreekrishna. 
necrosis factor 
1989 
expressed in E. coli in a partially K., et ai, (1989) 
soluble form. Synthesised as a fully Biochem. 28, 
soluble protein in P. pastoris. 4117-4125. 
Attained 0.108 g.rl.h-I by continuous 
culture fermentation. 
Mouse epidermal 1991 Investigated effects of media Clare2 J. 1., et 
growth factor composition on extracellular ai, (1991) Gene 
proteolysis and hence yield of this 105,205-212. 
small, disulphide rich protein. 
Tetanus toxin Investigated effects on expression of: Clare l J. J., et 
fragment C 
1991 
ai(1991)• site of genomic integration 
Bioffech 9,• 	 Mut phenotype 
455-460.• 	 gene dosage 
• 	 comparison of yield from shake 
flask cultures and fermentation 
Used HIV-ENV gene product as a Scorer. C. A. et 
marker to show there is a relationship 
HIV-ENV protein 1994 
ai, (1994) 
between copy number and resistance Bioffech 12, 
to the antibiotic G418. Showed 181-184. 
expression in general is limited by 
gene copy number. 
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Porcine leukocy1:e 1994 
12-lipoxygenase 
produced oxygenase 
characteristics more similar to 
by E. coli than the 
baculovirus-produced enzyme. 
showed a 90KDa 
yet known. Activity very similar to 
human cathe sin E. 
Developed rapid screening procedure Y., el 
(I 994)in 96-well culture plates, for 
active, gJycosy!ated protein with 
correct N-terminus roduced. 
Human cathepsin 1994 
Tick anticoagulant 
peptide 
transformants producing Bio/Tech 12, 
1119-1124. 
Mouse 
Xa activit I in 200111 cultures. 
Markus. H. W. 
seratonin rAr'An'rAr 
c-mcy tag between and 
AOXl promoter to allow immono­
detection of product. Found 
up to 8 times 
with roteo! ic minus 
Cloned in pro of a 
sequence 5' to gene, to allow 
correct N-terminal o[()cessn 
KEX2 protease in P. Fully 





to S. cerevisiae,cases, has proven a superior 
Comparisons made although this is not due to differences in 
back to the yield from S. 
cereV;SlGe was 1 monomers per 1OOmg of to O.02g11 (Valenzuela, 
1982), in contrast to 2.3 monomers (0.04g11) 1. M., et ai, 1987). 
outer membrane protein, n""nr.,,.., B. pertussis, a 
responsible for whooping cough in infants, was ,",U-'\OAllll S. cerevisiae and 
M, A., e! aI, 1991). With over 50 the recombinant vector, S. 
produced 0, 1% as P69 with 100% solubility. P. pas/oris produced P69 at a of 
O. a clone containing 30 but with less than 10% 
a form 
Usually there is a leap in flask culture to controlled fermentation 
conditions. ease with which protein pastoris can and it's 
ability to grow on inexpensive media has allowed a conversion to in most 
investigations. expression in S. on the other hand can difficult to scale 
up. In the over 3g/1 ofP69 was obtained in high density fermentation ofP. 
pas/oris this gene (Romanos, 1\1. ,et ai, 1991). A Mu( containing the tick 
anticoagulant produced 21 in shake flask culture increased to 
1. fermentation (Laroche, 1994). 
P. pastoris turned to as an to S. cerevisiae 

glycosylated One such protein is which is encoded by SUC2 gene ofS. 

cerevisiae. 1 F., el al (1 studied invertase expressed in systems: 

Recombinant invertase synthesised by pastoris; from wild-type S. cerevisiae and from the 

cerel'isiae, in a mutation in the endoplasmic reticulum is present. 
The content of each produced were by observing 
buoyant in a cesium chloride . Invertase type S. 
cel'el'isiae was higher in carbohydrate content than either of the two forms, which were 
This experiment demonstrated the difference in patterns of S. 
pas/oris. A subsequent investigation of the distribution and structure 
produced by pas/oris, showed a lack of terminal 
,3-linked mannose residues are characteristic of S. core oligo saccharides 
L. 	S. and Tschopp, J. Hence, a manner more 
to higher organisms. As 	 of glycan side VU(,J"Ui> important for 
and their passage the secretory pathway, the of using P. 
expression of glycosylated proteins is apparent. 
1t is now generally of recombinant from P. pastoris is largely 
protein-specific. Thus as a means of 
production, it is necessary to as much information about the 
characteristics and activity that protein. For instance, 115 is known to a 
of extracellular which place protease-susceptible products in \.Ialll!;:;"'1 
degradation. counteract unwanted proteolysis, protease-deficient strains 
developed such as invitrogen's SMD 1168. Other strategies include dropping the of the 
media to a point at which protease IS adding protein hydrolysates, to 
provide polypeptide chains that act as a "decoy" for protease action (Clare2, 1. et ai, 
1991 ) 
Further to point expression levels being protein specific, maximising dosage has 
actually resulted in a reduction in yield in some cases. For ,,,,,.u,,e,",,,",, of the mV-l 
gp 1 envelope protein decreased with containing any copy number above one 
(Scorer, CA, el 1993). It has been shown a protein requiring extensive folding, or 
containing a retention signal, may cause a blockage in the secretary pathway. IS 
exemplified by large surface protein of hepatitis B virus, accumulates 
subsequently causes enlargement of rough reticulum in mammals 
el aI, 1991). A the which is more likely to occur with 
can lead to cellular toxicity (Romanos, M. , 1992). As mentioned above, 
this may not be as a result of foreign protein accumulation but can be due to a 
limitation of resources for production of proteins and factors necessary cell 




A mer oligonucleotide (oligo), containing sequence for the J gene, was 
synthesised using solid phase phosphoramidite chemistry. Two containing 
sites RJ and Avr II, to cloning into plasmid PIC9, were also 
synthesised Forward primer design included an enterokinase site immediately 
5' to the first codon the CMT! J gene. codon S. cerevisiae was 
utilised for each The polymerase reaction (PCR) was used to 
modified CMTl J with the addition linkers containing restriction sites for 
Rl and Avr of the PCR product in the expected 
number and was then to pPIC9 cut at 
multiple cloning with Eco R] Avr II, and transformed into coli. 
Transformants were screened for the of an insert by amplification of the 
plasmid borne Three clones produced PCR products expected 
electrophoretic inclusion of the Sequencing of plasmid 
DNA isolated one such positive showed CMT! J to be in 
frame and of correct sequence. 
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3 Materials and Methods 
and bacterial strains, see appendix L 
1. Oligonucleotide synthesis 
(oligos) were synthesised in a 3' to 5' direction on an AutoGen™ 
using solid phase phosphoramidite chemistry. were 
from the resin by incubation in aqueous ammonia at room temperature 1.5 
in butanol in a ratio of 1: 1 0 v/v. The tube was 
and DNA pelleted by spinning at 12000rpm, ma 
Butanol was poured off and the pellet resuspended in 200!J,1 A 
below) for HPLC purification. 
HPLC 	purification and deprotection oligonucleotides 
Oligos were purified by anion a column. Elution 
butTers were as follows: 
A 50mM LiCI 
10mM NaOH 
pH 12.0 
B: 	 3~ LiCI 
10mM NaOH 
pH 11 
A linear gradient from 100% A to 100% B was run over 90 min. The peak containing 
DNA to which the trityl group was still attached, was collected and the DNA allowed 
to precipitate in 6 volumes 1.3 v/v ethanol to acetone, for 3 hours at -20°C. DNA 
was pelleted by at 12000rpm, for 20 min. This step was repeated on the 
supernatant to as much DNA as possible. 
Pellets were of the tritly group, (located on the 5' phosphate 
of were redissolved in 50!J,1 of cold aqueous 
was dried off, under vacuum, overnight at room 
temperature . 80111 of 80% acetic acid was added for half an hour to remove the trityl 
group . The detritylated oligos were reprecipitated in butanol and the pellets dissolved in 
200111 of 1 xTE buffer. The purity of each oligo was checked on a 20% denaturing 
polyacrylamide gel (c.f section 3.29.5). 
3.2.3. Concentration and prediction of annealing properties of Oligos 
OJigos were diluted 1: 100 in distilled water (dH20) and their UV spectra read between 
220nm and 280nm on a Beckman DU 650 spectrophotometer. The concentration of 
each oligo was calculated taking the optical density of 1 unit being equivalent to 
approximately 3711g1ml for single stranded DNA. The computer program Oligo, version 
3.4, was used to predict possible primer-primer interactions and secondary structures. 
Using this software, melting temperatures (Tm) for both forward and reverse primers 
bound to the 93mer oligo were predicted as 38.3°C and 47 .3°C respectively, in a 
buffer of l.SmM MgCh, SOmM KCI, lOmM Tris-HCI, pH 8.0. Tm in this case refers to 
the melting temperature of the double helical region between primer and template 
DN A. To determine whether the primers interacted with each other, approximately 111g 
of both primers were placed in the PCR buffer (lSmM MgCh, SOmM KCI, 10mM 
Tris-HCI, pH 8.0) and subjected to UV melting between 10 and 100°C on a Unicam 
1700 UV spectrophotometer. 
3.2.4. PCR amplification of the CMTI I gene 
Primers were diluted in dH20 to give a final concentration of 1pmolll1l. dNTPs were 
diluted in 1 xTE to a concentration of 8mM. A reaction cocktail was set up containing 
all reagents except the enzyme and primers, in order to provide a uniform mix for each 
reaction. All PCR was carried out in reaction volumes made up to 50111 with dH20 and 
covered with 50111 of paraffin to minimise evaporation. With the addition of primers and 
lastly enzyme, PCR reactions were set up as follows : 
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SAMPLE TEMPLATE REVERSE FORWARD TAQ. POL. BUFFER dNTPs 
NO. ng PRlMER PRlMER tmits ).LL OF l.5mM &.OmM 
pmol pmol MgCh /11 
1 500 20 20 1 2 0.5 
2 500 15 15 1 2 0.5 
3 500 10 10 1 2 0.5 
Control - 20 20 1 2 0.5 
A two step annealing procedure was used in the PCR reaction. The steps were as 
follows: 
1. Denature: 94°C for 20s 
2. Anneal reverse primer: 43 °C for 30s 
3. Anneal forward primer: 37°C for 30s 
4 . Extend: noc for 30s 
5. Final extension: n oc for 300s 
Steps 1 to 4 were repeated for 30 cycles, with step 5 as a final extension. Following 
PCR 10~1 were removed from each tube and subjected to 1.5% agarose gel 
electrophoresis. 
3.2.5. Restriction Analysis of the peR Product 
PCR was repeated and the products pooled. Four samples of 1O~1 each, were incubated 
separately for one hour at 37°C, with one unit each of the following restriction 
endonucleases : 
1. Hill/l 
2. Eco Rl 
3. Avr II 
4. Eco Rl plus Avr II 

Each digest was heat inactivated at 90°C for 5 min and then run on a 12% non­

denaturing polyacrylamide gel. 
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3.2.6. Preparation of pPIC9 
E. coli strain TOPI0F' (Invitrogen) was grown in LB broth to an optical density 
(600nm) of between 0.3-0.6. Competent cells were made from a 20ml culture and 
subsequently transformed with plasmid PIC9 (Invitrogen) by the method of Chung et 
ai, (1989). One such transformant was picked in order to isolate plasmid DNA. 
Plasmid PIC9 was maxipreped from a culture volume of 500ml by the alkaline lysis 
method (ClIrrent Protocols, 1989, unit 1. 7.). High speed centrifugation in a cesium 
chloride gradient was used to purify plasmid DNA (Current Protocols, 1989, unit 
I. 7.5 .), which was then dialysed against 1 xTE for 3 hours at 4°e. Precipitation of 
pPIC9 was carried out by the addition of 3M sodium acetate to a final concentration of 
0 .3M and 3 volumes of ethanol (Current Protocols, 1989, unit 2.1.1). DNA was left to 
precipitate at -20°C for 3 hours and the pellet recovered by spinning for 10 min, 4°C at 
12000rpm. pPIC9 was dissolved in 200111 of 1xTE and the optical density (260nm) 
recorded . pPIC9 was stored at -20°e. 
3.2.7. Restriction digest of pPIC9 
40111 containing 27.211g ofpPIC9 was simultaneously digested with Eco Rl and Avr II. 
Sticky ends were prevented from religation by the removal of 5' phosphate with calf 
intestinal phosphatase (Currel1l Protocols, 1989,3 .10.1) The reaction was stopped by 
incubating the mixture at 75°C for 15 min. DNA was phenoVchloroform extracted and 
precipitated with ethanol and 10% v/v 3M sodium acetate ( c.r. section 3.2.6) . The 
pellet was redissolved in 50111 of 1xTE and divided in two aliquots. One sample was 
split into five aliquots and run on a 0.7% low melting point agarose gel. Bands of 
linearised pPIC9 were excised from the gel and the DNA extracted using a Geneclean 
kit (US Biochemical cO/poration) . Purification by phenol chloroform extraction 
followed by precipitation with ethanoll 10% v/v 3M sodium acetate (c.r. section 3.2.6) 
was once again carried out on both Genecleaned and non-Genecleaned pPIC9. The 
concentration of each DNA was calculated from optical density (260nm) readings; one 
OD unit being equivalent to 50I1g!ml of double stranded DNA. DNA was dissolved in 
50111 of 1xTE and stored at -20°e. 
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3.2.8. Preparation of the PCR product for ligation 

Following PCR, was removed by at 37°C, with IIII of 
20mg/ml proteinase K to 20111 ofPCR reaction All protein was then 
removed phenol-~hloroform extractions and the subsequently 
precipitated v/v 3M sodium acetate section 3 6). The OD 
(260nm) was to calculate DNA (assuming lOD::: 
50llg/ml double DNA). A double A vr II was carried 
out simultaneously, by incubating the DNA with one unit enzyme at 37°C. The 
reaction mix was inactivated at 70°C for 5 min. were removed by 
chloroform and DNA precipitated 10% v/v 3M sodium 
acetate 3.26). 
3.2.9. the PCR Product to and transformation of 
coli 
The ligation reactions were out: 
"Geneclealled' linear pPIC9 600 PCR 
2. "non-Gellec/ealled' linear pPIC9 600 and 1000ng PCR 
were ligated by overnight incubation at 1 with 1 unit each 
(Current Pr%cols, 1989,3.14.1.). 
coli strain TOP 1 were prepared as above. 100111 of were 
ligation mix. The were set up: 
lIncut pPfC9 plus cells: to of transformation 
and the degree cell 
2. Cells only' as a control for the transforrnants 
.., 
J. Non-CfPed, Imearised pPfC9 cells: to establish whether of 
plasmid was complete, as any contaminating supercoiled plasmid will cause a 
background of transformants the gene insert ~~n....".., 
4. linearised plasmid pills to establish efficacy of procedure. 
tr.rlrr1'01t'An was out method of Chung et aI, (1 and 
transformants selected for on containing 
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3.2.9.1 peR screen of transformants 
Two 21 mer oligonucleotide primers with sequence homology to either side of the 
multiple cloning site (MCS) ofpPIC9 (sequences taken from the Invitrogen manual, ver 
3), were synthesised and purified as above. Tm values were calculated as 51. 7°C and 
54.3°C (in 1.5mM MgCb, 50mM KCl, 10mM Tris-HCl, pH 8.0) for forward and 
reverse primers (Oligo ver3.4). Single colonies of transform ants were placed in Iml of 
LB and grown overnight at 37°C. 5~1 of the resulting cultures were diluted with 95~1 
of dH20 and 25 ~l of these diluted cultures were boiled for 3 min. In all PCR, template 
DNA was provided from the addition of the above cultures, with a non-transformant 
being used as a negative control. The polymerase used was Dynazyme. Reactions were 
as follows : 
TElI,lPLATE 


















25 50 50 1.5 5 1.5 15 
PCR was carried out as follows: 
1. denature: 94°C for 20s 
2. anneal: 49°C for 30s 
3. extend: 72°C for 60s 
4. final extension: 72°C for 300s 

Steps 1 to 3 were repeated for 30 cycles with step 4 as a final extension. 

Following PCR, 1O~1 was removed and subjected to 1.5% agarose gel electrophoresis. 

3.2.9.2 Sequencing of the gene insert 
Clone 1 (see results) was chosen for sequencing. Plasmid DNA was first maxipreped by 
the alkaline lysis method and purified in a cesium chloride gradient, (c.r. section 3.2.6) . 
Sequencing was carried out by the dideoxynucleotide method (Current Protocols, 
1991, unit 7.4), using a Promega TaqTrack kit. Primers for sequencing were those 
previously synthesised for PCR screening of the MCS. 1.2~1 of 15pmoV~1 of 
recombinant PIC9 template was used per reaction. Sequencing gels were run at 
30 
50V/cm, a water to a constant temperature of Sequencing 
gels were dried on 3M Whalman filter paper wrapped in polythene, before exposure to 
X-ray film for 24 hours. Autorads were by emmersing the film in X-ray 
(AGFA Gl for 5 min, to treatment with fixing (A GF A 
rapid 5 min and washing with water. 
3.2.9.3 Agarose gel electrophoresis 
grade (Sigma) was dissolved in 1 to the percentage of weight 
to volume required. Ethidium bromide was added to a final concentration 0.5).1g/ml 
for visualisation of DNA was dissolved by boiling the solution in a microwave 
oven. Molten was poured into a 8cm x 15cm horizontal gel chamber containing 
a at one end. After the had set the comb was and the gel 
immersed in 1 Samples were in loading buffer containing] and 
1~I of bromophenol xylene tracking dye. were run at 6V/cm 1.5 
and 	 DNA visualised on a UV box at 254nm. 
3.2.9.4 	 Non-denaturing polyacrylamide gel electrophoresis 
acrylamide/ 1% bisacrylamide stock solution was diluted by the addition of 
and dH20 to give percentage acryJamide in solution required for the 
separation of DNA fragments, in a total volume of A 140mm x 9mm x lmm gel 
was polymerised between vertical plates, by the of 13 O~I of ammonium 
peroxidisulphate stock solution and 20).11 TEMED. Samples were run at 5V/cm in 
with dye in one lane, until Bromophenol Blue band' entered 
bottom buffer. were 10 min in a solution of of ethidium 
bromide solution and on a UV light at 
3.2.9.5. Denaturing polyacrylamide gel electrophoresis 
38% acrylamide/ 2% bisacryJamide stock solution was diluted by the addition of 
and plus urea to a concentration of 7M. gel was polymerised 
between vertical plates as above. Samples were prepared by 1:2 
recrystallised formam ide, and heating to for 20 min prior to loading. Gels were 
run hot at 20V/em, using 1 xTBE as electrophoresis buffer. 
Figure 5. 
Summary of cloning strategy 
oligo synthesis and purification maxiprep pPIC9 
t t 
PCR amplification of CMTI I gene double digest of 




restriction analysis of PCR product 
and Avr II 
removal ot5' PO, 
t with CIP 
double digest of PCR product with 








TRANSFORM into E. coli 
1 
PCR screen transformants 
t 
one positive clone chosen for plasmid maxiprep 
t 
plasmid sequenced across MCS 
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3.4. Results and Discussion 
for PCR amplification 93 mer oligo, care was to 
of secondary structure and self-annealing of the single CTT","","" 
pnmer would increase the vu"..uv,,,,., of obtaining one, uncontaminated 
PCR To permutations of the base """",AU....... 
were (aided by PrimerlGCG in order to obtain primers 
secondary structure. 
For the reverse primer, no sequence could found that would have less than 
pairs. This would probably result in the primer looping onto 
a structure, which could impair polymerase activity during PCR. 
To overcome this, an extra codon: was placed between the Avr II palindrome 
and codon in the reverse 7). Accordingly, 
codon was "'H"'~""'-' the 93 mer the 
total number ofcodons for binding the reverse primer to six. of AGC 
number of consecutive or CG base pairs within reverse primer to 
According to the laws of this structure is too unstable to form a 
at ionic strength. 
were placed on primer to efficiency of 
binding oftaq polymerase. they lay "outside" sites these 
codons would not be included in the cloned gene, such manipulation of 
also provided a means of formation. 
Furthermore, it should be that inclusion ofa start (ATG) at the 5' 
sequence was as this was provided upstream in the AOXI 
regIOn 
determine interacted, experiments an 
equimolar mixture ofboth were carried out. ...v«,,""< denaturation was 
observed and primer was therefore deemed 














PCR amplification of the CMTI I gene with the simultaneous addition 
of an enterokinase cleavage site at the 5' end and linkers containing 
restriction sites for cloning in pPIC9 
AGAGTCTGTCCAAGAATCTTG 
TCTCAGACAGGTTCTTAGAAC 3' 
, , , , , , , , II , , , , , :-' -------r-----, 
AGAGTCTGTCCAAG1GAACAGTAGCAGTA~CTTAAGATC 5' 
arg val cys pro arg
t 








II II II II II , II II ",,..---_-----t 
ACAAACCTTGTGCCAATGACACCAATTAG{ GGATCCr AGCTC 5' 






, :base annealment between 93mer oligo and primers 
~ : direction of transcription 
t : site of cleavage for enterokinase 
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multiple cloning site of pPIC9 downstream from the prepro 
..""""A.., of the S. cerevisiae a Kex2 protein produced by 
pastoris performs the initial prclce~;sUllg sequence, by cleavage 
cleavage of remainingArg and Glu as illustrated below 8). 
repeats are carried out by product. (Romanos, M. et ai, 1 
the diagram shows, co dons Val remain between this last 
the Eco RI site. Including v'V .... 'Vu'"' of the Eco RI site itself, 
should remain on the N-terminus number of extra amino 
to four. To facilitate correct "1"".('",,,, of N-terminus at a 
for enterokinase was included in the TO,.,<Xlg"rIsequence for the 
design. which converts trypsinogen to and has 
the recognition Asp-Asp-Asp-Asp-Lys. Cleavage occurs at bond 
formed nerwel:!n at its C-terminus, and so for 
this recognition was immediately 5' to the modified 
CMTllgene. 
Figure 8. 
Processing the signal sequence at the N-terminus of the 
fusion protein 
Kex2 
MFal s Val Ser Arg kIU Ala 
5'-- --------GTA CTC AAA AGA GAG 
Val Pro Arg 
.--------, , 3 GTA 
Eco RI Gene Insert Avr II 
The each oligo was optimised Saccharomyces usage. does 
not mean, that codons coli misincorporation ammo 
acids into product would necessarily occurred. preferences E. 
coli and S. cerevisiae only for proline, glutamine and (Ikemura, et aI, 
1982; Bennetzen, 1. L., and Hall, B. D., 1982), which are 
amino acids all present in L Documentation does lower occurnng 
for highly-expressed which codons rarely used are present M. A., 
] 992) Saccharomyces codon (which is near-identical to that of 
Ppaslor;s, (/Ill'ilrogell)) was advantageous. 
Due to a di fference in the Tm of forward and reverse primers, PCR amplification 
of was initiated a two step annealing of primers. This strategy should in 
principle increase binding efficiency of which has a melting 
temperature. The primer concentration on PCR are shown 
below. show an in product formation with increasing 
amounts pnmers. figure 5 it is that 20pmol of each can be used 
with no visible side 
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Figure 9. 













20 15 100M 
[primers] pmols 
M = pBR322-Hpa II digest 

(numbers with arrows represent base pairs) 

To determine if the peR product contained the correct sequence, a restriction digest 

was carried out with enzymes known to cut the insert. Restriction sites other than those 

known to occur (Eco R1 and Avr II) were located using the program GCG. Three 

cleavage sites for the restriction endonuclease Hill/I were predicted, which should 
























M 1 2 3 4 5 
M pBR322-Hpa II digest 
1. uncut PCR product 
2. Hpa II digest 
3. Eco RJ digest 
4 . Av/' II digest 
Eco RJ - A VT' II double digest 
(numbers with arrows represent base pairs) 
In figure 6, a slight downward shift in the mobility of fragments resulting from a double 
digest with Eco RlIAvr II is visible in lane 5. Single digests with each of these enzymes 
did not produce a visible shift . This is not surprising, as it is not possible to resolve such 
small changes in the molecular weight of the PCR product. In lane 3, a band appearing 
between 67- 76bp suggests a partial digest by HinfI. Two much smaller fragments, 
representing the 26bp and 32bp fragments , are also visible in lane 3 . The 23bp and 12bp 
fragments are not visible due to inability to resolve fragments of this size on a 12% 
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polyacrylamide gel. Even so, the electrophoretic mobilities of both uncut DNA and 
fragments generated by restriction digest, have the expected length. 
The results for transformation were as follows : 
Table 3. 
NillvIBER OF TRANSFORMANTS 
ng of insert "GENE CLEANED" 
pPIC9 + INSERT 
"NON-GENE CLEANED" 


















ND = non detected 
Clearly the Genecleaned plasmid did not produce as many transfonnants as the plasmid 
that was not purified. Genecleaning was used to remove any contaminating supercoiled 
plasmid that remained from an incomplete digest with Eco Rl and Avr II . This avoids 
the situation in which transformants are produced without the gene insert. It is possible 
that sodium iodide, used to dissolve agarose surrounding the DNA in this procedure, 
may have been present is trace amounts during ligation and thus have interfered with 
the action ofT4 ligase. The controls implied the following: 
control 1: competency of cells was satisfactory and the ability of pPIC9 to 
transform E. coli was good. 
control 2 : means of selection was satisfactory and no contaminating, ampiciIlin­
resistant microorganisms were present. 
control 3: an amount of contaminating supercoiled plasmid was still present with 
linearised pPIC9, conferring ampicillin resistance on these (false­
positive) clones. Thus the Bgl II digest was not complete. 
control 4: showed the efficacy of using CIP: this process was 93% efficient, as 
calculated from the ratio of colonies produced by controls 3 and 4. 
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Four colonies were picked at random for PCR screening (denoted clones 1 to 4) . 
Primers synthesised for this purpose were those recommended by Invitrogen (manual 
ver 3) for sequencing These 21 mer oligos had sequence homology to areas within the 
AOXI promoter region, 3' and 5' to the MCS, such that the inclusion of an insert 
would cause a change in the electrophoretic mobility of the PCR product. Results of the 
PCR screen are shown below 
Figure 11 
















M 1 2 345 
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4, clone J 
5, 4 
(numbers with arrows represent base pairs) 
1,3 4 show the shift mobility, ~~,_"..,_~ these 
transformants (Note that the resulting from the 
lambda (21 1bp), did not appear due to percentage agarose), Clone 1 was 
chosen sequencing was subsequently maxipreped for this purpose. 
As the forward primer lay some 389bp upstream from the Rl difficulties were 
with in this over entire as 
reverse just 100bp downstream the Avr II site, a clear sequence could 
be in this direction, running the for about 3 hours at SOV/cm. Sequencing from 
the reverse primer was repeated in order to identify GC artifacts and ensure the 
was In with the pPIC9 reading frame. The could read upto 6 




Sequence read from the reverse primer in a 5' to 3' direction 
5' end Avr II 
TTA AAT CCG CGG CCG CCT AGG CGA TTA ACC ACA GTA 
TTA ATT CGC GGC CGC CCT AGG CGA ITA ACC ACA GTA 
ITA ATT CGC GGC CGC CCT AGG CGA TTA ACC ACA GTA 
ACC GTG TTC CAA ACA AAC ACA TTC AGC CAA ACA GTC 
ACC GTG TTC CAA ACA AAC ACA TTC AGC CAA ACA GTC 
ACC GTG TIC CAA ACA AAC ACA TTC AGe CAA ACA GTC 
AGA GTC CTT CTT ACA TTC CAT CAA GAT TCT TGG ACA 
AGA GTC CTT CTT ACA TTC CAT CAA GAT TCT TGG ACA 
AGA GTC CIT CIT ACA TTC CAT CAA GAT TeT TOO ACA 
GAC TCT CTT GTC ATC GTC ATC GAA TTCTAC GTAAGG 
GAC TCT CTT GTC ATC GTC ATC GAA TTC TAC GTA AGG 







first experimental sequence 
second experimental sequence 
expected sequence 
codons in italix: recognition sites for Eco RI and A VI' II 
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4.0 	 Cloning of the modified CMTII gene into P. 

pastoris and selection of MutS clones 

4.1 	 Summary 
Plasmid DNA, containing the CMTlI gene insert ( referred to as cmti-PIC9 in the 
following sections), was transformed into spheroplasts of P. pasLoris. A novel method of 
transformation was used, whereby spheroplasts were electroporated in the presence of 
linearised , cmti-PIC9. Forty three transformants were selected by their ability to grow on 
agar lacking histidine . To identify clones of Mue phenotype, their rate of growth was 
studied on minimal media containing methanol. Nine of these transformants grew slowly on 
methanol and were selected as likely candidates for containing the gene inserted into the 
genome. Total DNA was isolated from these putative MutS clones and PCR amplification 
of genomic DNA carried out, using primers with homology to the AOX J locus. Three 
clones produced a PCR product of identical electrophoretic mobility to cmti-PIC9. 
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4.2 Materials and Methods 
For media see appendix 1. 
] Bg/ II digestion of cmti-PIC9 
Plasmid DNA was prepared by the lysis method (Current Protocols, 1989, 
1.7.) R.NA was removed by incubation for 1 at 3 with 100 Ilglm I A A 
restriction digest of20llg ofDNA with 2 ofBgl II was then carried out for 1 hour at 
37°e cmti-PIC9 was subsequently purified by phenol-chloroform 
and precipitated with ethanolllO% v/v 3M sodium acetate (c.f section 3.2.6). 
4.2.2 Preparation of a growth curve for P. pastoris 
pas/oris, GS 115, was provided as a stab culture (Invitrogen). GS 115 was 
streaked for single colonies on YPD agar and grown for 2 days at 300 e colonies 
were used to inoculate 3 McCartney bottles 5ml YPD each. Starter 
were grown overnight, on a shaker, at 30°C and the following used to inoculate 3 
conical flasks containing 50, 200 and 500ml of A 50ml culture of S. cerevisiae was 
also in the study. Cultures were grown for hours and Iml removed every hour, 
8 to hours post inoculation (hpi) (collected by experiment such that 
readings were taken from a to 12 hours and 12 to 24 hours). The optical density (600nm) 
was recorded for sample and graphs plotted of absorbance versus hpi. Samples with 
an optical density than 2 were further diluted and the OD then multiplied by the 
dilution in order to within working of the spectrophotometer. 
4.2.3 Preparation of spheroplasts 
100m] of spheroplast suspension was prepared according to the method Cregg, 1. M. et 
at (1 In addition to this protocol, another 200111 of 0.3 mglmllyticase (Sigma) and 
200f.l1 of 1 M were added, 2 hours after initial addition of enzyme. The of 
spheroplasting was established at regular intervals as follows. min, 1 III of 
culture was removed and diluted l' 100 with 5% absorbance (800nm) of this 
solution was recorded and the of spheroplasting calculated using the 
% spheroplasting 100 - [(OD800 at time t/OD8oo at time 0) x 100] 
approximately 70% spheroplasting was the solution was divided in two and 
labeled as sample 1 and 2. Sample 1 was pelleted by gentle centrifugation at 1500rpm, 4°C 
for 2 The pellet was washed in 1 M sorbitol, 10mM Tris 7.5), 10mM 
repelleted and stored on Sample 2 was prepared for electroporation, washing once 
with 200ml of ice cold water and twice with 200ml of 1 M sorbitol. Spheroplasts of sample 
2 were pelleted as and also left on ice. 
PI'eparation of carrier DNA for transformation 
The sodium of type III from Salmon testes (Sigma) was dissolved in lxTE to a 
final concentration of 10mg/mt solution was overnight at 4°C to ensure the 
DNA was completely dissolved and frozen in Iml aliquots at -20°e. One aliquot was 
into four equal portions and sonicated for 7, 15, 30 and 60 seconds respectively. 
Samples were cooled on ice immediately following sonication to prevent heat denaturation. 
was then extracted with phenol-chloroform and precipitation with ethano1l1 0% v/v 
3M acetate, (cf section 3. optical density (260nm) was recorded each 
sample, and 1 IJ,g run on a agarose gel to visualise the extent sheering. this way, 
conditions which produced DNA between the desired molecular 
weights of were used to prepare a fresh sample carrier DNA transformation. 
4.2.5 Transformation 
Pellets of 1 and 2 were resuspended in 40% 3350, 1M sorbitol, 25mM 
(pH 8.0) in an approximate 1'1 (w/v) ratio of biomass to solution. Sample 1 was 
incubated 50~lg of DNA and 1 ofBg/ II-cut cmti-PIC9, for 10 min at room 
temperature. Sample 2 was treated in a similar manner, but with just 100ng II-cut 
cmti-PIC9 no this controls 50/-t1 spheroplasts were set up 
sample, without plasmid DNA 
Cells of sample 1 were harvested by centrifugation as above and the solution 
aspirated The pellet was resuspended in a la-fold volume of 1 M sorbitol, 10mM 
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10mM CaCho (pH 7.5), and left for a further 10 min at room temperature to encourage the 
recovery of spheroplasts. Finally, cells were suspended in 10ml of molten RD agarose at 
45°C which was spread on to RDB agar. Plates were incubated at 30°C until colonies 
appeared. 
Standard electroporation curves were prepared in 1M sorbitol. 50111 aliquots of 1M sorbitol 
were placed in cuvettes and pulsed with 0.9, 1.2 and 1.5KY. For each voltage, 
characteristic decay times were obtained depending on the preset resistance, using a 
constant capacitance of 251lF. Resistances which gave decay times around 10ms were used 
for electroporation. 50111 aliquots of sample 2 were electroporated under the following 
conditions : 




CAP ACIT ANCE 
J.lF 
1 0.2 0.9 400 25 
2 0.4 1.8 600 25 
3 0.4 1.8 800 25 
control 0.4 1.8 800 25 
Immediately following electroporation, Iml of ice-cold 1M sorbitol was added to the 
cuvette to provide an osmotically stable environment for the recovery of the yeast. Cells 
were suspended in 10ml of molten RD agarose at 45°C, which was spread on to RDB agar. 
Plates were incubated at 30°C until colonies appeared. 
4.2.6 Preparation of glycerol stocks 
Transformants were assigned a number for identification, streaked on to YPD agar and 
grown for 2 days at 30°e. Single colonies were placed in testubes containing 1 ml of YPD 
and grown overnight, shaken, at 30°e. Glycerol stocks were prepared by mixing 0.5ml of 
overnight cultures with O.5ml of sterile, 50% glycerol, and stored at -70°e. 
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4.2.7 Screening transformants for phenotype 
One ml cultures each transformant were grown from single colonies as above. Mut
S 
control strain was also included in screen, the gene serum 
albumin (BSA) cloned at AOX 1 locus (Invitrogen). Two 1O1l1 aliquots culture 
were placed in testubes, one of which contained Iml of minimal dextrose media (MMO) 
and the other, 1ml of minimal methanol media (I\1M:M). Cultures were grown to mid 
phase amount of biomass formation compared by to that of the Mue control 
exhibiting turbidity of the broth identical to that of the control were selected. 
4.2.8 Preparation total DNA 
Total DNA was isolated from selected as follows: 2mJ cultures were grown 
overnight in cells by centrifugation at 12000rpm, 4°C, 
3min. Total DNA was extracted by the ma "'...."'.lUF. buffer 
glass (Curren! Pr%cols, (1989) unit 13.11.3.). was separated from proteins 
by repeated phenol/chloroform extractions and precipitation in ethanoU 10% v/v 3M 
sodium acetate section 3 The optical densities at 260nm and 280nm were 
recorded The 260nm was to calculate approximate DNA 
concentration (1 OD == double stranded DNA) the ratio of was 
to a rough of protein still present. 
4.2.9 screen of genomic DNA 
PCR was usmg total DNA preps to template DNA. Primers 
were those previously used for sequencing, having homology to 3' and 5' AOX I 
sequences. PCR was out using the polymerase Thermoprime Plus (Advanced 
Biotechnologies). Conditions were first optimised using as DNA. 





negative control 	l' total DNA isolated the BSA-secreting control 
control 2: pPIC9 
were diluted to a final volume 50111 with dH20 and covered with 50111 



















200 50 50 1.0 6 5 0.5 
PCR was carried out as follows: 
1. denature: 94°C for 20s 
2. anneal: 49°C for 30s 
3. extend: 72°C for 60s 
4. final extension: 72°C for 300s 

Steps 1 to 3 were repeated over 30 cycles with step 4 as a final extension. 






4.3 Results and Discussion 

are three techniques for transfonning yeast cells: by rendering cells competent for 
uptake ofDNA using lithium by electroporating cells in the ofDNA 
and by spheroplasts. will on the 
which transfonnants are intended, the and availability of time and equipment. 
majority ofcloning experiments in pastoris have employed the spheroplasting 
technique. was refined 115 by et in 1985, based on method 
developed S. cerevisiae by Hinnen et al (1 Examples ofproteins expressed 
spheroplast transfonnation pastoris, include expression of the gene for bovine 
lysozyme et aI, 1989) and the tetanus fragment C , J. J., et 
1991). Electroporation has successful as a means of transfonning P pastoris, for 
example, the expression oftick anticoagulant peptide (Laroche, Y., et aI, 1 The 
lithium acetate method has been less popular, especially in recent years. group to use 
lithium acetate was Cregg, 1. M., et (1987), in expressIOn B surface 
antigen. 
all three it is important to know the growth hence number 
cells/ml, V.H'''',",'''',",''' by the density of the at 60Onm) before transfonnation is 
attempted. For S cerevisiae, transfonnation lithium acetate is optimal a culture 
an optical density (600nm) electroporation the preferred 
between 1.3-1.5 for spheroplasting 0.5-1.0 is (Current Protocols, 1989, 
unit 13.7.1). explanations these differences, rather they to 
investigators have found to work for that particular method 
transfonnation. HU,""J"'C> to transfonn pastoris are on the techniques documented 
for S with or no alteration. Yet it cannot be assumed that P. pastoris 
exactly same mean no... o.-''''".-,,., time or requirements. Thus it was vVl.'''lU,",l 
to study growth pastoris prior to transfonnation. 13 
shows growth curves for P. pastoris and S. (8): 
Figure 13. 





6 8 10 12 14 16 18 
-+ 
hours post inoculation 
In order to attain the desired density of cells for transformation, different volumes of YPD 
were inoculated with the same volume of starter culture and the rate of biomass formation 
was studied. Both 50ml cultures did not appear to grow exponentially, suggesting the 
media volume to be inadequate to support logrithmic growth from an inoculum of this 
density. These graphs provided guide lines as to the culture volume required to attain the 
specified cells/ml from an overnight incubation. These results also indicate the mean 
generation time for S. cerevisiae is slightly shorter than for P. pastoris in this media, as 
shown by a shift to the left of the growth curve of S. cerevisiae. Studying the growth of P. 
pastoris enabled a general feel for the organism, and throughout this project the above 
graphs were frequently referred to. 
Prior to spheroplasting, attempts were made to transform OS 115 using the lithium acetate 
method. This was initially the method of choice because it is relatively short and simple, 
with transformation efficiency expected at 105-106 cells/Ilg transforming DNA for S. 
cerevisiae (Current Protocols, 1989, unit 13.7.1). However, every attempt resulted in a 
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smear on selective Contamination was unlikely as only yeast were 
under the microscope a sample was examined. addition, they had a 
characteristic yeast odor and yet distinct colonies, even after dilutions, could not 
obtained. After several attempts, was turned to as a ",,,,,,vuv means of 
Interestingly, came to at the Invitrogen 
Diego, In 1996, in which investigators claim to have 
problems transforming pas/oris via the lithium acetate method. Indeed, the 
updated (verE) from li1l'ilrogen warns that the response pastoris to lithium 
acetate found to be poor 
are yeast cells from which wall has removed, the cell 
membrane cells appear more rounded under the microscope compared to 
a "ghost" Spheroplasts the ability to take up 
Preparing spheroplasts is a process requmng expertise, 
addition to an enzyme used to components of the cell wall, an 
expensive However, spheroplasting is only technique 
of P. paslOris containing multiple copies gene 
makes it an choice for as clones have been to express 
recombinant at levels than containing just one copy section 2.2). 
Enzymes used to digest the cell wall of yeast, are aided by the on:~seI1ce a 
reducing agent as DTT or p-mercaptoethanol. A second addition 1M 
DTT was lJ""·au~,,, the rate of formation was slow. 
After spheroplasting a number of times I found it was preferable to add a amount of 
enzyme for a than with less as cell lysis 
was microscope after about 2.5 However, transformation 
frequencies remained unsatisfactorily low and in an attempt to boost this, PIP('r ..'r.nr."~lt'r. 
of spheroplasts was investigated. 
The following the Bgl II cleavage was complete (lane 
fragment insert. Uncut (lane 1) exhibited two forms of 
DNA, 15 
Figure 14. 




1. 11lg cmti-PIC9 
2. 11lg Bg/ll digested cmti-PIC9 
Spheroplast stock solution was split in two in order that one sample be subjected to 
electroporation after the addition of transforming DNA Uptake of DNA by spheroplasts is 
aided by the presence of carrier DNA (large fragments of double stranded DNA), and 
polyethylene glycol (PEG) of a specific molecular weight. Carrier DNA was not included in 
the transformation of sample 2 because it is known to inhibit uptake of plasmid DNA 
during electroporation In addition, the amounts of transforming DNA differed: just JOOng 
of cmti-PIC9 was added to sample 2 as amounts in excess of this cause a drop in 
transformation frequency from electroporation (Current Protocols, 1989, unit 13.7.3). In 
order to keep all-things-equal, both samples were incubated with transforming DNA for 10 
min, although it is unlikely that spheroplasts of sample 2 took up DNA at this point, due to 
a suboptimal amount of cmti-PIC9 and lack of carrier DNA 
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Prior to transformation, standard curves for electroporation in 1M sorbitol were plotted. 
The following graphs show that changing the voltage had a negligible effect on decay time. 
Figure 15. 
STANDARD PLOTS TO OBTAIN DECAY TIMES IN 1M SORBITOL 












200 400 600 800 1000 
RESISTANCE ohms 
Electroporation conditions were chosen to give decay times around 10ms, as recommended 
by /l1l'ifl'Ogen. Thus a voltage of O. 9KY and resistance settings between 400 and 800 ohms 
were chosen (note that only resistance settings in multiples of200Q were possible with this 
apparatus). A control was included, in which spheroplasts without transforming DNA were 
electroporated at SOOn. 
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Results of transformation of samples 1 and 2 were as follows: 
Table 4. 







1 1000 not 
electro po rated 
N/A N/A none 
2(a) 100 0.9 400 6.9 32 
2(b) 100 1.8 600 11.7 11 
2(c) 100 1.8 800 13.3 none 
control 1 none not 
electro po rated 
N/A N/A none 
control 2 none 1.8 800 13.3 none 
Colonies were not recovered from sample 1 and the greatest number of transform ants 
resulted from electroporation of spheroplasts from sample 2, at 0.9 KV/cm and 400ft The 
controls showed a) the selection procedure for transformants on agar lacking histidine was 
successful and b) no auxotrophic revertants or contaminants able to grow on the selective 
agar were present. 
At the 1nv; trogen conference, March 1-4, 1996, opinion was still divided as to whether 
electroporation or spheroplasting gave the best results for transformation ofP. pastoris 
(personal commlfn;cation). Our results show that combining these two techniques is a 
viable option. However, it cannot be said whether transformants arose from the uptake of 
DNA into spheroplasts or merely ordinary cells remaining in the spheroplasting solution. 
Had sample 1 produced transformants, comparing the number of colonies from sample 1 
and 2 would have shed some light on this. Indeed, the absence of colonies from sample 1 
was surprising: certainly spheroplasts appeared viable under the microscope prior to 
transformation and it is possible that the amount of DNA used (1 J..l.g) was insufficient. To 
our knowledge, electroporation of spheroplasts has not been attempted before and may be 
55 
investigation strains which are difficult to transform by 
means. 
initial screen for MutS transformants was out in broths, (Prof Dowdle, 
personal commlllllca!lOn) as we found the test using 1\11\1 and MD 
(Invitrogen manual 3) produced a large colonies. inclusion of 
a of melhano/-uli/isalioll-s/ow was important in enabling 
the clones of this type, as well as a means expression conditions 
In clone provided secreted bovine serum albumin 
liSA gene is inserted at J genomic locus via a 
event. To keep the experiment simple, we to initially screen for just 
MutS 
Of the 43 9 displayed a similar rate of growth in Hll.'.u .... to 
secreting control expected these tubes were the initial 
inoculum I O~L1 whereas cultures PVTrA('p as the food 
source (l'vIMD) were clones were considered as until the 
absence or J gene insert in the shown by PCR. 
Results PCR screen . DNA are shown overleaf: 
Figure 16. 

10% non-denaturing PAGE of peR screen of genomic DNA 

622 - =7 
527 -? 












M 1 2 3 4 5 
M: pBR322 Hpa II digest 
1. pPIC9 (no insert) 
2 . cmti-PIC9 
3. clone 9 
4 . clone 21 
5. clone 29 
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Clones 9,21 and 29 3,4 and 5) a PCR of identical mobility to 
positive control lane 2 (cmti-pPIC9), This showed that contained 
inserted into did not produce a 
product, which would negative controL PCR conditions were 
USIng as template conditions have been unsuitable for 
amplification of a much larger this being some 30000bp the gene, 
possibility having obtained a product from amplification of plasmid was 
ruled out as P. pas/oris not have episomal vectors (c,r section 2,2), 
peR not positively the site integration, nor any information as 
to the .."-,c..."",,, of multiple copies inserted into the genome. this, hybridisation to a 
DNA probe by Southern blotting is on both counts. However, the plasmid was 
to at the A 1 locus, as with Bg/ll would produce a 
fragment with 5' 3' ends homologous to 1 sequences, as a MutS 
phenotype was observed, thereby' disruption of the A OX J structural it is 
likely that t clones did indeed from of the at the AOXJ 
locus via a transpJacement event. 
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1 
5.0 Expression, isolation and identification of 

recombinant CMTI I 
ummary 
the cmti-PIC9 gene product from P. pastoris, was out in a 
on the method of Clare et ai, (1991). 
signal sequence, enabled recovery of the recombinant 
product the culture supernatant. The fusion protein, now referred to 
was . assay of the culture supernatant for anti-tryptic 
-Benzoyl-L-arginine-4-nitroanilide hydrochloride (BANA) as a 
purification procedure was developed for the isolation 
the peak containingjCMTl was identified by assay for 
analysis and protein sequencing were then used to 
batch jCMTI was expressed and isolated in the 
same way, in the N-terminus by at the enterokinase site. The 
modified product was ';;)Vi""",U identified as recombinant CMTl I by 
protein 
59 
5.2 Materia and Methods 
For see I 
5.2.1 Expression conditions 
Clones were streaked single colonies on agar and grown for 2 days at 30°C. 
A starter culture was grown hours at by inoculating of with 
three or four colonies. Cells were harvested the following morning by centrifugation 
at 3000rpm, for 10 min. The pellet was resuspended in SOml of minimal tT''''''''''-'' 
(MGB) in a conical and shaken 7 hours at Cells were 
harvested as above and the resuspended SOOml of minimal methanol broth 
(l\1MB), in a two litre culture was aerated by pumping air 
nPT·cn.>v tubing, a 0.22 micron filter to remove air-borne A 
second, sterilised tube allowed the removal of carbon dioxide produced from 
aerobic respiration of yeast, and was fitted at end with a 0.22 micron filter. 
culture was shaken 4.S at 30°C, with the addition of methanol every 
hours. 
As a control, a second culture was set up on a smaller scale, in which the pellet 
grown 7 hours MGB was resuspended in MGB. Cells from both 
cultures were harvested by centrifugation at 12000rpm, 4°C lOmin. 
supernatants were decanted and stored on ice prior to dialysis. 
Time course assay using the BSA-secreting control (Invitrogen) 
A small scale from the MutS control strain was out 
accordance with the above protocol. 1 ml aliquots of culture were removed at 
approximate 12 hour intervals, for 4.5 days induction. Cells were harvested at 
12000rpm for 1 in a microcentrifuge. lOOIl! of sample was 
volume by freeze drying, to an amount that could be loaded into the lanes of a 
(about 341l1), and mixed with 6111 of 6xSDS loading buffer (Current Protocols, 1989, 
unit 10.2. Samples were at -20°C prior to analysis by (c.r 
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5.3. lOfJl of "large molecular weight proteins" (Sigma) and 1f..!g of 
commercial BSA were used as markers. were stained with Coomassie Blue 
to photography (section S.3.2). 
5.2.3 DiaJysis and freeze drying 
ester dialysis tubing, with a cut off pore lOOOD (Spectra/Por), was 
prepared several in distilled water. SOml aliquots of culture supernatant 
were dialysed against Slitres dH20 for 6 hours at 4°C, with changes of dH20 every 
2 hours. The contents of each were then poured into round bottomed 
flasks, rotating the flasks in an ethanol bath at and placed 
under vacuum for 24 hours. 
5.2.4 Gel filtration 
Sephadex (GSO fine) was swollen in an elution of20mM Tris-HCI (pH 8.0), 
according to the manufacturers instructions. The gel was """'E'>""''''''''''"' and poured into a 
8Scm long, with a 3cm. Sephadex was to pack 
a fiber filter then placed on top of the column. The was sealed at either 
end producing a closed system and allowed to equilibrate in elution buffer. 
outlet tube was connected to a UV detector, which measured the optical density 
the at 229nm. eluent was collected in testubes, in 3ml usmg an 
automatic fraction collector. The output from the was monitored on a 
usmg (courtesy ofDr. D. U.C.T.). Column were 
obtained from the elution profIles for dextran blue and vitamin B which elute in 
outer inner volumes respectively. 
were redissolved in a minimum amount of dH20 and 6mlloaded 
onto column at a time for chromatography. corresponding to the 
each were freeze dried in and the material obtained redissolved in 300f..!i 
dHzO. lOOfJl aliquots were for anti-tryptic (c.r S.2.8) and an 
average rate reaction determined. 
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phase HPLC using trifluroacetic acid (TFA) 
The fraction from Sephadex column filtration which vl'UllU""U anti-tryptic activity was 
split into portions and subjected to reverse HPLC on a Vydac C 18 
column, following buffers: 
Buffer 
Buffer B. 0.1 
acetonitrile 
A gradient was run 100% A to 100% B over min and peaks collected in 2ml 
eppendorf tubes. were dried down under vacuum resuspended in 300lli 
of dH20 Each was then assayed for anit-tryptic .>...,vava 5.2.8). 
5.2.6 Reverse phase using hydrofluorobutyric acid (HFBA) 
The fraction Qn.', _TrUTH.,... activity from the first was 
subjected to reverse using the same column and buffers: 
Buffer A 0.1 
Buffer B: 0.1% 
100% 
A gradient was run from 100% A to 100% B over 45 min and 
collected. The isolate was activity 8), and 
characterised by amino acid and sequencing. 
Detection of anit-tryptic activity in culture supernatants 
Bovine pancreatic trypsin (Sigma) was dissolved in dH20 to a final of 
5mg/m1. A 10mM stock solution -Benzoyl-L-arginine-4-nitroanilide 
hydrochloride (BANA, Merck) was by first dissolving 43mg in 2ml 
methanol, and adding dH20 to a final volume 10ml. The assay buffer was 1 
20mM CaCh, (pH 8.0). O. of induced culture supernatant was m 
a cuvette with 2. solution and 2.45ml of buffer. 
was mixed and for 10 min, after which 50111 of 
solution was A was fitted to the cuvette and the contents 
mixed by inverting 3 or 4 times. cuvette was placed in a Beckman 
spectrophotometer and in optical density (405nm) measured 
O. over Assays were in an identical manner with uninduced culture 
supernatants, The rate of measured as mols of nitroanaline released per 
was calculated from change in absorbance/ using the formula 
Lambert: 
A~50 = I.C.8 
~511 is the absorbance solution at I is the path length the 
cuvette; c is the concentration of the substance monitored and E: is 
coefficient in L mOrl. obtain the amount nitroanaline released in this 




Where the extinction 
(Merck, EC. 3 
Detection anti-tryptic activity in fractions from filtration 
and HPLC 
Fractions collected from column chromatography and HPLC, were the 
gene product by of anti-tryptic activity. In each case, fractions coinciding 
dried and in 30011-1 dH20. 10011-1 
aliquots were for in a volume of Iml, using the 
procedure in sec~no'n 5 7. The same final concentrations of solutions were 
used. In order to minimise pipetting errors, an average rate was from the 
three readings. 
Just prior to the pH of the solution was checked with paper to confirm 
that it had not away from no other interfered with 
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of trypsin, control were carried out on fractions collected during a 
reading from and the rate of reaction calculated as above. 
Performic acid hydrolysis and amino acid 
UV spectrum of the isolate was measured between 200 Protein 
concentration was then optical density 1 unit (230nm) == 
protein. A volume approximately Snmols was placed in an acid­
tube and the dried. 
In to measure the amounts of cystein, performic acid oxidation was carried out 
prior to ammo acid analysis. was made by mixing and 95111 
of acid and allowing the reaction to proceed at room for 2 hours. 
acid was then sample and 3 5 hours. 
sample was then diluted 200).11 of dH20 and dried. 
The sample was dissolved in 100).11 of and degraded to single amino acids by a 
20 hour hydrolysis with boiling HC!. to prevent the ammo 
acids, was performed a flushed with to 
remove inclusion of 5% to mop up any excess 
One the hydrolysed sample was "'''''''.'''u with orthophthaldehyde, which 
bound to amino acids. acids were separated by cation 
detected by monitoring (338nm) and VAAL'''' ..",..,. 
(425nm) for HPLC were: 
Buffer A 0.2M sodium nitrate, pH 3.] 
Buffer B sodium borate, pH 9.5 
Elution using 1 acid. 1 nmol ofNorleucine 
was included in as an internal blank run was also performed 
to enable subtraction of dirt peaks. 
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1 Protein sequencing 
of the N-terminal amino acids was out degredation 
and Begg, ,1 20pmolof inhibitor was dissolved in 15J.lI of 
the N-terminal amino group coupled to phenylthiohydantoin on a solid 
support. Sequential degredation of amino acids the N-terminus was performed in 
acidic conditions. The residue could during each of 
its elution HPLC 
Enterokinase cleavage ofjCMTI 
One containing 30J.lg of enterokinase Kf>,M"".'UT~'" Manheim) was 
dissolved in 30~L1 dH 20 to give a concentration of Imglml. of 
solution was added to approximately of in a buffer of 50mM 
Tris-HCL 0 80, (pH 80), solution was at 37°C for 15 
hours, which the reaction was stopped by placing the tube in boiling water 
min. The cleaved/eMTl product was then purified by reverse phase HPLC 
o 1% as the ion pair (c.r 5 6). The to 
major was dried, in dHzO and by amino 
analysis 
5.2.9.3 	 Sodium dodecyl sulpha polyacrylamide gel 
electrophoresis PAGE) 
SDS PAGE was out a version of developed by 
(1970). Currenl ProlOco/s, (1989), unit 10.2). were run at 5VIcm 
until the tracking entered the bottom tank buffer. To over-heatingI1111j'1111.,... 
plates were cooled with a fan. Bands were visualised after JV"LAU•.'!". three 




5.4 Results and Discussion 
It is generally accepted that expression levels from P. pastoris are largely protein 
specific (Invitrogen conference, March 1996, personal communication). As such, 
expression conditions should be optimised for each protein and in doing so special 
attention must be paid to the composition of the media. Clare2 1. 1. et al (1991), 
investigated the effects of media composition on levels of extracellular expression of 
the mouse epidermal growth factor (mEGF), from both S. cerevisiae and P. pastoris. 
In both cases it was shown that yields of mEGF were greater from expression in rich 
media than in defmed media. For P. pastoris they found that adding cas amino acids 
(hydrolysed casein) to the defined media, or lowering the pH, resulted in a reduction 
in proteolytic activity and consequently an improvement in yield. It is believed that 
small polypeptide chains in rich media, (provided by yeast extract and peptone), divert 
the activity of these extracellular proteases. Such "decoy" substrates were provided by 
the addition of cas amino acids to their defined media. 
Attempts to expressjCMTI were first carried out in the rich induction medium; 
buffered methanol-complex medium, (BMMY, Invitrogen manual 3). During the 
isolation procedure an oily brown residue was obtained, which was difficult to 
remove. This residue derived from the complex components ofBMMY (i.e., yeast 
extract and peptone) and difficulties were envisaged in separating these substances 
from a small protein such asjCMTI. To overcome this problem, a medium of known 
composition was used instead. The major component of this medium was yeast 
nitrogen base (Y.NB), which contains all the essential amino acids, vitamins and salts 
to support the growth of yeast. The media and method adopted were based on those 
developed by Clare l , 1. 1. et al (1991) Cas amino acids were however, excluded, as 
this component would cause problems similar to that ofBMMY. 
Cregg et al stated: "we have found that induction is highly sensitive to factors such as 
agitation rate and dissolved oxygen concentration." This finding was echoed at the 
IIll'itl'Ogell conference in March of this year (personal communication), where the 
importance of using baffied flasks to increase surface area for oxygenation, was 
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agreed upon. Due to the unavailability of this apparatus, our system involved pumping 
sterilised air into a culture, which was agitated by placing the bottle on a shaker. In 
this way adequate aeration was provided for the needs of expressing cells. 
In order to verify conditions as being suitable for expression, a time course assay of 

the BSA-secreting Mut' control strain was carried out. Figure 12 shows a 10% SDS 

PAGE gel containing samples of induced culture supernatant taken at approximate 12 





10% SOS PAGE of time course assay 
108 96 	 87 72 63 48 40 24 18 0 BSA M 

hours post inoculation 

M : 	 molecular weight markers for SDS PAGE (Sigma) : bovine serum albumin 
(66KD); egg albumin (45KD); g1yceraldehyde-3-phosphate dehydrogenase 
(36KD); carbonic anhydrase (29KD); trypsinogen (24KD). 
BSA : 	 l!lg of commercial bovine serum albumin 
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Recombinant BSA did not appear until 40 hpi, showing this to the time 
for of amounts Coomassie stain. The 
amount of recombinant produced 108 hpi was calculated companng 
results a densitometric scan of tills band and the band produced by 1 j.lg of 
commercial BSA ((lane "BSA") scans not shown). Tills was detennined as of 
recombinant which extrapolates to an estimated of 40mglL results of 
the time course assay that conditions were suitable to induce satisfactory 
expreSSlOn the MutS control However, it not be uU'~U,",u 
from tills data that production ofjCMTI would necessarily result in the same yields. 
a of interest, an extra band can be seen lane which did not m 
the standard (Figure 17). Another gel, in willch the bands were visualised by the 
more sensitive silver staining method, a ladder ofbands directly under each 
band of recombinant (data not shown). were likely to degredation 
products from the action of extracellular proteases. The time course assay 
a dual purpose, by drawing attention to the problem extracellular 
proteolysis recombinant proteins by P. 
documented in reviews Cregg, J. et ai, (1993) and Romanos, M.A., (1 
Fortunately, CMTI I is known to be extremely to by 
enzymes than (Otlewski, J., 1993). cases of at 
sites within the inhlbitor do exist, instance porcine pepsin was shown to 
Leu7-Met8 bond (Otlewski, et ai, inherent, protease­
resistant nature of CMTI I allowed us to the possibility of proteolysis as a 
mmor concern. 
the expression of recombinant proteins pastoris, it is desirable to separate 
the biomass and synthesis section 2.2). For MutS 
which grow slowly on methanol, (doubling time of 18 hours, Invitrogen) it 
was necessary to bulk up in tenns of total biomass prior to induction. Accordingly, 
biomass was increased fold at every This provided a large number ofcells, 
which have an additive effect on yield. A starter was obtained 
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(about 1020 cells/ml) by nTrt.""Tn of the initial for 36 hours 
This was followed by a 7 hour incubation in ~"'.u..'u containing glycerol as 
the source. This would provide cells in the log phase of growth (Figure 
13, with the AOXI promoter tightly With the 
methanol, would start about 40 hours post induction, -:If'£'(U',(l1n to 
the results the time course Figure 17). 
In order to jCMTI, ~.,,~u.,.,.u were first made to visualise the recombinant 
product PAGE methods developed for the resolution of small A 
time course was carried out the conditions V"","Uj,,",Y in section 
SDS-P AGE usmg a FY- .... u acrylamide 12-26% of the• ....",.. 
polyacrylamide solution (DeWald et ai, 1986). were also run on a 
tricine-SDS discontinuous being particularly useful for the 
resolution of proteins under 10KD. (Schagger H. and von 1987). 
staining of did not produce distinct bands under a weight 
5KD. This was to a obscuring this region, caused 
by small COlnpc:me:nts media each sample. overcome this, 1ml 
aliquots of supernatant were dialysed to remove media components, and 
reduced in drying to electrophoresis. a band 
approximating to molecular weight the cmti-PIC9 could still not 
be visualised with certainty. Gel was to be an 
unsuitable means this in as yet, quantities. 
Anti-tryptic activity was detected by <;:(,f'PP1'1 the supernatants 
cultures, of the VHJ.U"""' previously shown to contain a genomic cmti-PIC9 
Assays were out using 
as a substrate, and competitor, for (see next 
for description trypsin-BANA interaction). For each clone, an 
uninduced culture was set up to provide a control for any "'V"., .. ,"'"' in the media 
may have caused inhibition. BSA-secreting 
MutS clone was also <U'T'PP1'Pti for anti-tryptic activity, as a control trypsin 
arising from pv....rp<:, cultures. results are shown in following 
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bar chart, in which an average rate from induced and uninduced culture supernatants 
of the MutS (BSA) control (which were near identical), was subtracted from the rates 
obtained from culture supernatants of clones 9, 21 and 29: 
Figure 18. 
Trypsin assays carried out on O.Sml of induced and 






























O.5ml of induced (+) and uninduced (-) 
supernatants from clones# 
Induced culture supernatant from clone 21 (bar 21 +) exhibited the greatest anti­
tryptic activity. The controls (uninduced supernatants) showed some variability in 
rate of reaction, notably, uninduced clone 29 appeared to exhibit a low level of 
trypsin inhibition. However, this was considered to be within the experimental error 
of the assay, as it is important to realise that these assays were not carried out under 
analytical circumstances. Indeed, the assays in this section were not intended for any 
accurate measurement of inhibition but merely as a means of detecting the 
recombinant product. Nevertheless, the rates obtained were clear in showing clone 21 
as the best candidate for expression of jCMTI. 
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An isolation procedure was developed, whereby (at each stage) the fraction 

exhibiting trypsin inhibition was purified until a homogenous protein was obtained. 

The first stage involved the removal of the majority of media components by dialysis. 

Gel filtration was then used to separate large proteins from the active fraction, as well 

as any remaining media. Finally, two sequential steps of reverse phase HPLC were 

used to purify the inhibitor to homogeneity. 

A defined medium was chosen to enable the separation, by dialysis, ofjCMTI (M
f 

predicted as 3863D), from components in the media of lOOOD and below. Dialysis 

was kept to a maximum of 6 hours, with frequent changes ofwater, to minimise 

losses ofjCMTI. Following freeze drying of the dialysed solution, some media 

components were still apparent due to a distinctive yellow-green tinge. Subsequent 

passage through a Sephadex GSO column enabled separation ofjCMTI from these 

remaining contaminants, as well as from the bulk of other proteins. The elution 

profile from gel filtration is shown below: 

Figure 19. 
Elution profile of 3ml fractions in 20mM Tris-HCI, pH8.0, 
























Sephadex G50 fine was chosen in order to give the greatest resolution of proteins around the 
predicted molecular weight ofjCMTI. Peak 1 eluted in the outer volume and contained large 
proteins of 30KD and above. Peak 3 eluted in the inner volume and probably contained salts and 
residual media components: as implied by the distinctive colour and odor of fractions 40 to 48. 
Peak 2 eluted between the inner and outer volumes, thus making it the prime candidate for 
recovery ofjCMTI. Trypsin assays were performed on fractions corresponding to the apex of 
each peak. The rates of reaction obtained are compared in the following bar chart: 
Figure 20. 
Comparison of rates of reaction from fractions 
corresponding to the apex of each peak from gel 
filtration 
0.004 














It is clear that peak 2 contained a trypsin inhibitor(s). The control consisted ofan 
assay carried out on fraction 1, which would have contained the elution buffer and 
any contaminants eluting at low levels from the column. Fractions 24 to 28 were then 
freeze dried and subjected to reverse phase HPLC, using 0.1 % TF A as the ion pair. 
























Elutiion time, min 
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10 60 
In order to identify the active fraction, peaks 1 to 6 were freeze dried and assayed for 
anti-tryptic activity. The rates of reaction obtained are compared in the following bar 
chart: 
Figure 22. 
Comparison of rates of reaction from fractions 
corresponding to peaks collected during HPLC 
0.005.--------------------------, 













The peak exhibiting trypsin inhibition (peak 3) was easily identified. The control 
included an aliquot collected before commencement of the gradient (in buffer A), in 
which the absorbance had not moved from the base line. Peak 3 eluted 22.5 minutes 
in to the gradient, at 40.5% acetonitrile. 
A further purification step was carried out on the active fraction, by submitting it to 
reverse phase HPLC using a different ion pair. The following chromatogram was 
obtained from HPLC using buffers containing 0.1 % HFBA: 
Figure 23. 
Second HPLC purification of the active fraction 
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Elutiion time, min 
The major peak was collected, eluting 30 minutes in to the gradient at 66% 
acetonitrile. 
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Amino acid analysis was perfonned on the isolate as well as a sample of native 
CMTI I extracted from the seeds of squash (donated by Prof. J. Otlewski, University 
ofWroclaw, Poland). The analyses showed, within the experimental error (see 
section 6), that the protein isolated was indeed the recombinant fusion protein (c.f. 
figure 25). 
The fusion protein was incubated with enterokinase to obtain recombinant CMTI I 
with the correct residues at the N-tenninus. Enterokinase cleaves the peptide bond 
between the Lys of its recognition site and first residue (Arg) of CMTI I (c.f. figure 7, 
section 3.4). Another batch of jCMTI was expressed and isolated for this purpose. 
The products of enterokinase cleavage were separated by reverse phase HPLC, using 
0.1 % HFBA as the ion pair. Figure 19 shows the chromatogram obtained: 
Figure 24. 
HPLC chromatogram of the fusion protein after cleavage 
with enterokinase 
















20 30 40 50 60 
Elutiion time, min 
o 10 
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28 minutes in to the gradient, at 62% acetonitrile. 
was a reduction in the elution time of the major peak, i:)U,,;~v':HH.L~ 
hydrophobic. The extra peak (when compared to 
at HUIlY"_'" was ...."''''YJ.l.'-'..... to be enterokinase. The identity of the major peak was 
analysis and N-terminal sequencing of this 
Figure 25 of amino acid analysis for jCMTI, 
jCMTI and show the recombinant form I had the 
within the error 
Prior to amino was oxidised using performic acid in order 
to measure must be converted to cysteic acid 
in order to of hydrolysis. The amounts of cysteic acid 
measured were present in each 
acid nevertheless occurred. 
One notable discrepancy in was the absence of tyrosine in the native 
inhibitor. It can be that to degredation oftyrosine (an amino 
acid known to do so during this nrr\I'Pr1n1rp than to its actual absence. The 
harsh conditions of performic acid VAH.""'UU'H responsible for the absence of 
methionine and proline, which cannot method of 
amino acid analysis. In addition, a dirt was 
responsible for the large area under the histidine 
Protein sequencing provided the ammo at 
inhibitor. ForjCMTI the sequence was: 
VaI- Giu - Phe - Asp - Asp 
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CleavedjCMTI and native CMTI both had the following sequences: 
Arg - Val - X - Pro - Arg 
Where X represents an amino acid that could not be identified by sequencing. The 
native sequence of CMTI I was published in 1983 by Wi lutz et ai, in which the first 
five amino acids were found to be: 
Arg - VaI- Cys - Pro - Arg 
As cystein is known to degrade under conditions of acid hydrolysis, it is likely that X 
was indeed cystein and that a recombinant form of CMTI I, with the same 
composition as the native protein, had indeed been synthesised. 
The occurrence ofVal-Glu-Phe on the N-terminus ofjCMTI was expected, as codons 
for these residues form part of the mUltiple cloning site ofpPIC9, lying 5' to the first 
amino acid (Asp) ofthejCMTI gene (c.f. figure 8, section 3.4). Interestingly, amino 
acid analysis of the batch of jCMTI produced for enterokinase cleavage revealed an 
abnormal amount of tyrosine, and on sequencing the N-terrninus the following 
residues were obtained: 
Tyr - VaI- Glu - Phe - Asp 
This sequence implied a variation in the site ofcleavage of the STEl3 gene product, 
an enzyme produced by P. pastoris to trim extra amino acids remaining after Kex2 
cleavage of the signal sequence (c.f. section 3.4). Cleavage was expected before the 
tyrosine in the latter sequence because it was preceded by Glu-Ala repeats: the 
recognition sequence for STE13. Why this variation in processing occurred can only 
be speculated at from the data obtained in this study. However, it can be said that 
expression of CMTI I as a fusion protein provided a degree of control in obtaining a 
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6.0 Determination of Ki for fCMTI, recombinant 

CMTI I and native CMTI I. 
6.1 Summary 
of trypsin activity were performed in ofjCMTI, recombinant 
CMTI I and native CMTI 1, to obtain inhibitor. Native CMTI I was used as 
a control, to which the activity of the inhibitors were compared, 
were manner N-Benzoyl-L­
arginine-4-nitroanilide n\!t"lrrH'n Lineweaver-Burke plots 
were constructed with inhibitor to determine the apparent 
Km values, Ki values for were obtained from plotting apparent Km 
versus inhibitor concentration, constants were: 3 0-7M, 2, llxlO-7M and 
2, 17x10-7M for./CMTI, I respectively, No 
reduction in activity was recombinant I containing eight extra 
amino acids at the N-terminus, recombinant inhibitors are almost identical 
to that of native CMTI I, structural determinants for their activity are 
presumed to be correct. 
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6.2 Materials and Methods 

6.2.1 Stock solutions 
10-5M trypsin 

24mg of pancreatic bovine trypsin • (Sigma) was weighed out to one decimal place and 

dissolved in 100ml of 100mM Tris/HCI, 20mM CaCb, (pH 8.0) in a volumetric flask. 





43mg ofN-Benzoyl-L-arginine-4-nitroanilide hydrochloride (Merck) was weighed out 

to one decimal place and dissolved, while stirring, in 2ml methanol. 100mM TrislHCI, 









The concentration of each inhibitor was calculated from the results of amino acid 

analysis. A mean value in nmols was obtained from the amount of each of the amino 

acids, with the exclusion of those known to degrade during hydrolysis. 

6.2.2 Instrumentation 
All assays were performed on a Beckman DU 650 spectrophotometer, using the 
kinetics software therein to provide rates of reaction. This was given as change in 
absorbance (at the specified wavelength) per minute. Error margins for each rate were 
also provided based on regression analysis of the plot. Gilson pipettes were assessed for 
precision by weighing distilled water on a micro balance. The average error was 
calculated by regression analysis and factored back in to the pipette settings for all 
assays . 
. This product is giYen as being predominantly the (X form of bovine pancreatic trypsin. 
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6.2.3 Assays to obtain Km and V max for trypsin 
Relative substrate concentrations between 1 and 10 were calculated to values 
between zero and no greater than 1,5 Km for trypsin et ai, 1961), 100111 
of trypsin stock solution was added to amounts ofBA.NA corresponding to 
concentrations in a quartz cuvette and cuvette placed on a balance, Assay buffer 
was immediately added to the mixture until the weight of the solution reached 
exactly, cuvette was stoppered, inverted 3 or 4 times to mix the contents and 
placed in the sample holder of the spectrophotometer. Changes in absorbance (405nm) 
were at 0,5 second intervals over 200 seconds, at room temperature (22°C). The 
in absorbance per minute and standard deviations were recorded and to 
disk. The cuvette was rinsed with dH20 between readings, and with 10% SDS to 
remove any residual trypsin which have adhered to the A reciprocal plot of 
rates of ~,..,~...~. substrate concentration was to obtain I1Vmax and -l!Km 
(c. f section 
6.2.4 Inhibition assays 
AI: 10 dilution of inhibitor solution was made in distilled water. 100111 trypsin 
stock solution was incubated at room temperature (22°C) for 10 min with a known 
amount of inhibitor. relative concentrations of BANA were calculated between 0 
and 1,5 of the experimentally determined Km. A of were thus set up by caLUUI 
amounts of substrate to the pre-incubated trypsin-inhibitor mix. After 
addition of BAN A to the cuvette, the volume was immediately made up to 1m! with 
assay buffer as above. Spectroscopic monitoring of the rate reaction was carried out 
c.r section 6.2.4 Apparent values were obtained from plotting liS versus IN. 
6.2.5 Determination of Km and Ki 
The Michaelis-Menten equation was used to determine the maximum velocity of 






V (Mis) the rate of reaction, Vmax the maximum rate, Krn (MI) the 
substrate concentration. For convenience, this was 
into Lineweaver-Burke to plots: 
1 Km 1 1 
---- (2)
V V max [S] V max 
can be obtained from the slope equation 2 and 
(3) 
The range of was chosen to values conveniently spaced between 0-1.5 Krn for 
the reciprocal plot. 







Where E is enzyme; S the 
complex; I inhibitor and the enzyme-inhibitor complex. inhibition constant 
Ki, is as: 
(4) 
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equation for competitive inhibition under steady state 





Ksll + [IJ) + [S]
\ KI 
(5) 
equation may rearranged into a reciprocal as follows: 
This provided a number of apparent 
1 
-+ 
[S] V max 
values from the intercept 
(6) 
each plot with the 
x axis (-llKm describes 











Where each plot has a slope = Km app/Ymax, and : 
Kmapp = Km( 1+ ~D (7) 
Km 
or: Kmapp = Km + Ki [I] (8) 
The standard derivations (sigma), were calculated by the method of Bevington, P. R. 
(1969), for Km and Ki. According to equation 8, a plot ofKm app vs. [I] will result in a 




y-intercept = Km (10) 
It follows from equations 9 and 10 that the Ki values can be obtained from: 
Ki = y int ercept (11 )
slope 
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6.3 Results and Discussion 

Kinetic experiments were carried out in order to compare the inhibitory properties of 
the two recombinant inhibitors, to that of native CMTI 1. The binding characteristics of 
squash inhibitors rely primarily on conformation, which in tum is largely dependent on 
disulphide bridge formation and topology (c.f. section 1.3). This data would therefore 
show whether P. paslOris was a suitable expression host for the biosynthesis of these 
small, disulphide rich proteins in an active form. In addition, the effects on Ki of the 
extra amino acids at the N-terminus of the fusion protein, would be shown. 
The first experiment involved a determination of the Michaelis constant (Km) for the 
reaction of bovine trypsin with N-Benzoyl-L-arginine-4-nitroanilide hydrochloride 
(BANA) The structure ofBANA is shown below, the arrow indicating the site of 
trypsin cleavage. Cleavage occurs at the peptide bond of arginine, with the liberation of 
4-nitroaniline (in brackets) . This substance absorbs in the visible range of the spectrum 
at 405nm, such that the reaction mix became increasingly yellow. 
Structure of SANA 
H 2 N C NH-(CH )' - -CH-C~'NH-l-~ NO 
23 I !I ~- 2 
HN NH 0 
, ' 
\\ ,;'- C = O 
Rates of reaction were measured with increasing amounts of substrate, the 
concentrations of which did not exceed l. 5 Km (Erlanger, B .F. et ai, 1961). Amounts 
of substrate were chosen such that reciprocal values would produce evenly spaced 
points on the subsequent Lineweaver-Burke plots. Assays were performed in as 
uniform a manner as possible, with pipettes being calibrated prior to use. The 
Lineweaver-Burke plot for Km and Vmax is shown below: 
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Figure 27. 
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V"'''.,,",vu was expressed as amount IDllroanalme liberated per seCIDna 
equation 2, Km for trypsin was "'...n" .."' ...""'.... as 52.2xlO-5M ± 6.23xlO-6 • 
concentrations were determined by <UUiUV acid analysis (c.f. section 
7.0xlO-5M ± 1 
I: 8.7xlO-5M ± 1 
CMTII: 9.4xlO-5M ± 1 
measure the activity ofeach rates of reaction were <....u;'u",,,"" over a 
of lI[S] vs. IN f'f'"""t'nlf'tPr!inhibitor concentrations 
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Apparent Km values with increasing concentrations of jCMTI are given below: 
Table 5: Km apparent for fCMTI I. 
!II of 1: 10 inhibitor 








0 0 5.22xl0-4 ±6.23xl0-6 
5 3.50xl0-8 5.78xl0-4 ±1.45xlO-5 
15 1.05xl0-7 6.95xl0-4 ±1.30xlO-5 
20 1.40xlO-7 7.4lxlO-4 ±1.19xlO-5 
The experiments were repeated for recombinant and native CMTI I, after cleavage of 
the N-terminal peptide from jCMTI with enterokinase (figures 29 and 30): 
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Figure 29. 










-4000 -2000 o 2000 4000 6000 8000 10000 12000 14000 
1/S (M-') 
Km app values for the native inhibtitor are given below: 
Table 6: Km apparent for native CMTI I. 
III of 1 : 10 inhibitor 







0 0 5.22xl0-4 ±6.23xlO-6 
13.1 1. 14xlO-7 6.70xl0-4 ±2.0xl0-4 
29.9 2.60xl0-7 9.19xl0-4 ±6.3xl0-4 
39.2 3.41xl0-7 12.99xl0-4 ±1.6xlO-4 
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Figure 30. 
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Km app values for recombinant CMTI I are given below: 
Table 7' Km aggarent for recombinant GMTI I 
~l of 1: 1 0 inhibitor [inhibitor] Km apparent standard deviation 
stock added M M sIgma 
0 0 4.1x10-4 ±1.1x10-4 
9A 8.0x10-8 6.49x10-4 ±3_0x10-s 
18_5 1.73xlO-7 8.l5x10-4 ±1.7x10-4 
37_0 3A6x10-7 11.83x10-4 ±5.4x10-4 
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To obtain Ki values for the inhibitors, apparent Km values, as predicted from 
Lineweaver-Burke plots were plotted against inhibitor concentration. 









































(1 E-7) 0 1E-7 2E-7 3E-7 4E-7 
[I] (M) 
Figure 33. 
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analysis of the above plots 31, enabled calculation of 
are gIVen ininhibition constants for each inhibitor to 11. 
table 8: 
Table 8: Ki for fCMTII, recombinant CMTII and native CMTI L 
INIDBITOR Ki (M) standard 
derivation (sigma) 




The standard derivations are very small and the correlation (R2) for 
werewhich ranged between 
inhibitors were very similar, especially The inhibition constants 
native and forms. This infers that recombinant CMTI I was 
folded protein and therefore the topology ofthe disulphideproduced as a 
bridges matches 
recombinant ,",,,,...,u,,,,,,,,,, mismatched disulphide bridges, or incomplete 
(1992), who synthesised three 
native inhibitor (c.f. section 1.4). the 





"_,",'ICTP'" pair substituted with Gly 
of an analogue ofCMTI III 
Elimination of any 
in a decrease in the association constant by several 
Kupryszewski et (1 that two incorrect 
an molecule. 
• CMTI ill differs from CMTI I only at residue 9, which is instead of Glu. 
92 
rangmg 10-8 to 1 M. This may due to the used study being an 
undefined of both a a predominance of the The a 
form is known to have a lower affinity for BANA than the ~ (Schroeder and 
Shaw, 1 which explain this However, as the Ki of the 
recombinant inhibitors were the same as that of CMTI I, a comparison 
activity was still possible. 
The extra residues on the N-terminus of the batch of jCMTI for which Ki was 
determined were: 
Val-Glu-Phe-Asp-Asp-Asp-Asp-Lys 
results show that addition this particular peptide to the N-terminus CMTI I 
did not In any reduction in the inhibition constant. It would be interesting 
to do structural studies on this elongated inhibitor to see how residues interact 
with the core the inhibitor and/or trypsin, if indeed they do. However, research 
lies outside of the of this MSc. thesis. 
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Concluding Remarks 
active of CMTI I were synthesised by recombinant DNA technology in 
methylotrophic P. . Inhibition constants were determined as 3 0-7M, 
2.11xl and 2.1 10-7M for jCMTI, recombinant CMTI I and CMTI I 
respectively. Comparison these strongly suggests that the recombinant inhibitors 
were folded in correct manner. This answered initial question posed regarding the 
ability P pas/oris to sythesise and fold small, disulphide rich proteins. 
A other inhibitors have cloned. et af (1 cloned a 
synthetic gene for rrichosanthes trypsin inhibitor (TTl) mutated at position 6. This inhibitor 
was both in coli and S. cerevisiae, the latter expression system producing 
superior yields of over 2mg/1. The inhibitor was expressed as a fusion protein containing 
3 extra amino on the N-terminus the yeast-expressed protein, and showed inhibitive 
properties similar to natural 
Wen, L., el al (1993) CMTI V in E. coli, also initially as a protein. CMTI V 
is actually 68 amino acids in with' one disulphide and is classified as a 
pumpkin inhibitor (although still a member of the Cucurbitaceae). fusion protein 
contained 7 extra amino acids on the N-terminus, and showed a reduction of 50% in inhibition 
its enzyme W-factor XlIa) as compared to CMTI V. Bolewska, et 
al (1995) expressed a synthetic for a I analogue in coli, modified at the 
by a substitution Met8 Leu. for this analogue was the same as native 
CMTI I, and yield obtained was 
It is difficult to an accurate measurement recombinant CMTI I produced here, as it 
was subjected to a four purification, prior to obtaining correct sequence by cleavage 
with enterokinase. From the absorbance (229nm) of peaks (peak from first of 
HPLC, the yield of the fusion protein was estimated as 2 L 4mg/L yield is typical of 















N -Benzoyl-L-arginine-4-nitroanili de hydrochlori de 
PIC9 containing the CMTlI gene 
water 
dithiothreotol 
hours post inoculation 
inhibition constant (M- I ) 
Michaelis constant (M- 1) 
multiple cloning site 
minimal glycerol media (non-induction media) 





regeneration dextrose (agar) 
total cell protein 





Bacterial and yeast strains 
coli TOP 1OF' was provided Invitrogen corporation, CA, 
USA, as a culture. TOP] OF' is as follows: 
, lacZL\M15, TnlD } merA, L\(mrr-hsdRMS-mcrBC),F' 
15, L\lacX74, L 39, L\(ara-leu)7697, galK, 
elidA 1, llltpG"A-
Diego,strain GS 115 was provided by the Invitrogen 
, as a stab culture. 
115 genotype is his-l. 
plasmid PI C9 
is a 8023bp fusion vector produced by the corporation. (For 
see introduction, pas/oris as an host). 
Diluted from a stock buffer 
10xTE stock solution 
lOOmM Tris-HCL pH 7.6 
lOmM EDTA, pH 8.0 
Diluted from a stock of 10xTBE 






to one litre 
Broth was aloquoted into glassware, autoclaved at 14psi. 
as above with addition of 15g 







was all solids were poured in to 11 reagent bottle and 
autoclaved at 1 agar was added to 
sterilisation. When cool, 100ml of 10% was added. was stored "'VIU'UVI 
at 4°C. 
As taken from 
....."....., was of dH20 1 added. 
For base sorbitol was 700ml of dH20 of agar added. 
Both media were sterilised by autoclaving as above and placed in a water bath at 60°C. 
The following were then added plates poured for was 
retained molten at for the addition transformants following spheroplasting 
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13 
Media components added to agar: 
.. 100ml of sterile 1 solution 
.. 100ml of stock solution 
.. 2ml solution 
.. 10ml solution 
.. 88mlof water 
without amino (DIFCO) 
was dissolved in 100ml dH20 by heating gently, sterilised a 0.2 
micron filter under pressure. 
20mg biotin was dissolved in 100mi dH20 and filter sterilised as above. Stored at 4°(. 






40mi (2%) of 10% glycerol 







of 10% methanol 




Anthony. (1982) Academic New York 
W. M. and E. H., (1902).! 28, 
Bennetzen. 1. and Hall, , (1982).! Bio. Chem. 257, (6) 3026-3031. 
Bevington, K (1 Data reduction and error analysis jor physical sciences. 
McGraw-Hill, N. 
K, el aI, (1991) DNA. Cell. 10,191-200. 
Bode, W. and K (1992) Ellr . .! Biochem. 433-451. 
Bode, W, el .! Mol. 112. 
Bolewska, K, et aI, (1 174. 
el aI, (1 89, 2172-21 
Clare! l l, el al (1 9,45 
1. el al (1 1) Bio/Tech 9, 455-460. 
1. 1., e / ( 1991 ) 12. 
Clore, M.. el (1987) Eng. J, 313-318. 
1. .elal,(1993)Bio- ll, 10. 
1. M., el aI, (1993) Bio/Tech JJ, 10. 
1. M. el aI, (1985) Mol. Cel/. 
Cregg. J M., el aI, (1987) Bio/Tech 5, 
1. and W., (1 Acta Crystallogr. 238-250. 
DeWald, D. B. el aI, (1986) Anal Biochem 502-508. 
Digan, M. E, el (1989) Bio"Tech. 7, 160-164. 
Drenth,1. 1. N., el (1971) Enzymes (ed. P Boyer),3rd 3, 484 Academic 
NY 
Edman, P. and G., (1967) ElIr . .! Biochem J, 80. 
B. F. e/ aI, (1966) Biochem. Biophys. Acta J 116. 
Favel, e/ (1989) 1111. .! Prot. 
Finkenstadt, W. R., el al (1974) Symp. 5, 389-411. 
S and Tschopp. 1. (1988) Yeasl 106-115. 
Grasberger et aI, (1 SlruclUre. 2, 669-678. 
99 
et al. (1991) 10, 1-2642. 
Hamata, N, ef al. (1995) 1. 
Hara, S., el ai, (1989) 1. 
Hayashi, K, et al. (1994) 1. 
Heitz, A, el al (1989) 
Hinnen, A P., el al (1987) Mol. 14: 
IHolak, T A, Gondol, D., 1. and Wilusz, , (1989) 1. Mol. BioI. 210, 
648. 





Huang, Q, el al (1992) 7, 143-146. 

Huang, , el al. (1 in China 33, 1192-1200. 

Huber, R, el (1 Mech 1, 189-201. 

Huber, R, el (l 73-101. 

Ikemura, el ai, (1 J. 573-597. 

Kupryszewski, ,el ai, (1 41,1422-1 

Kupryszewskki, et ai, (1986) 11ll. 1. Peptide Protein Res. 27, 

Laemmli, U. M. (1 ) 1. Mol. BioI. 80, 

Laroche, Y., ef Bio'Tech 12, ]] 19-1124. 

Laskowski, Kato, 1. (] 980) AIlIlU. Rev. Biochem. 

Laskowski, R W. (1971) The Enzymes 3, 

M., el ai, (1987) Biochemistry 26, 202-221 
et al. (1989) Biochem. Biophys. Res. Com, 1430. 
el (1 ) Biochim. Polon 30, ] 138. 
S. (1995) Nat. SIr. Bio, 7. 
Lipscomb, W N . el PNAS64, 28. 
Markus, H WeI (1 FEBS lell. 451 
, el al. (1983) Acta C,ystallogr 
Matsuo. M., el ai, (1992) Biochim. Biophys. 1 
McGrath. M. , elal, (1995) Protein Sci. -I, 14]-148. 
McWerter el ai, (1989) Biochemistry 28, 14. 
M.. el al. (1991) 1. Mol. BioI. 219, 10. 
100 
Nowak, el al. (1981) Hoppe-Seylers Physiol. Chem. 1017-1019. 
Otlewski, 1. (1 BioI. Chem. Hoppe-Seyler. 3 suppliment., 
Otlewski, J (1993) The Squash Inhibitors ojSerine Proteinases in Innovations on 
alld their Inhibitors (Aviles, F.x., Ed.) pp de Berlin 
J (1 Prot. 55. 
Otlewski,1. and Wilusz, T (1 Acta. Blochim. Polon. 32, 
Otlewski,1. and Zbyryt. ,(1994) Biochemislly 33.200-207. 
Otlewski, L el al. (1994) Biochemistry 33, 13 
Polanowski, A., et al. (1980) Acta. Blochim. Pol. 27, 1-382. 
A., el (1987) Acta. Biochim. Polon. 395-406. 
Quast, V. el al. (1978) Biochemislly J7, 1 1682. 
R. G., el Biochem. Biophys. Comm. 381-388. 
Reich, Ritken (1 Proteases Biological Control. Cold Harbor 
Laboratory. 
el al. (1960) J. BioI. Chem. 1686-1 
Rolka, K., (1 BioI. Chem. Hoppe-Seyler. 370,499-502. 
Rolka, el al. (] ) Bio!. Hoppe-Seyler, 3 63-68. 
K., el aI, (1 Chem. Hoppe-Seyler 373, 1 1060. 
, el ai, (1 1) Vaccine 9,901-906. 
Romanos, M. A., el (1992) 423-488. 
Romanos, M, (1995) Curr Opin Biotech 6, 
Rozycki, J., el al. (1994) Biol. Chem. Hoppe-Seyler, 21 
H. von Jagow, (1987) Anal Biochem 166, 
Schechter. I. and A. (1967) Biochem. Biophys. Commun 27, 1 
Schroder, D. and J. Bio. Chem. 2943-2949. 
CA., el al. (1 111-119. 
Scorer. A., el at. (1994) Tech 12, 81-184. 
Sharp, PM., etal. (1988)N. A. 16, (17) 8207-8211. 
Sreekrishna, . et ai, (1 Biochem28,411 125. 
Struhl, . (l ) Nature 305, 391 
The (1970) Lodder. 1 North-Holland publishing co. ArnsterdamILondon. 
Tschopp, 1. el ai, (1987) Bio Tech 5, 1 1308. 
101 
Valenzuela, P. , et aI, (1982) Nature 298,347-350. 

Vozza, L. A. , etal, (1996) Bio'Tech 14, 77-81. 

Wen, L., et aI, (1993) Protein Expression and Purification 4,215-222. 

Wieczorek, M., et aI, (1985) Biochem. Biophys. Res. Commun. 126, 646-652. 

Wilusz et aI, (1983) Hoppe-Seylers Z. Physiol. Chem. 364, 93-95. 

Wilutz, T., et aI, (1983) Hoppe-Seyler's Z. Physiol. Chem. 364, 93-95 

Wynn, R and Laskowski , M. Jr., (1990) Biochem. Biophys. Res. Comm. 166, 1406­
1410. 

Xiao-Ming, C , et al. (1992) 1. Biochem. 112,45-51. 

Yamada, M, et al. (1994) BBA 1206,279-285. 

102 
